Background  ||| S:24 E:43 ||| NN
The  ||| S:43 E:47 ||| DT
cullin ||| S:47 E:53 ||| JJ
/ ||| S:53 E:54 ||| NNP
RING  ||| S:54 E:59 ||| NNP
family  ||| S:59 E:66 ||| NN
of  ||| S:66 E:69 ||| IN
ubiquitin  ||| S:69 E:79 ||| JJ
ligases  ||| S:79 E:87 ||| NN
comprises  ||| S:87 E:97 ||| VBZ
a  ||| S:97 E:107 ||| DT
multifunctional  ||| S:107 E:123 ||| JJ
set  ||| S:123 E:127 ||| NN
of  ||| S:127 E:130 ||| IN
enzymes  ||| S:130 E:138 ||| NNS
controlling  ||| S:138 E:150 ||| VBG
the  ||| S:150 E:154 ||| DT
stability  ||| S:154 E:172 ||| NN
and  ||| S:172 E:176 ||| CC
activity  ||| S:176 E:185 ||| NN
of  ||| S:185 E:188 ||| IN
cell  ||| S:188 E:193 ||| NN
cycle  ||| S:193 E:199 ||| NN
regulators ||| S:199 E:209 ||| NNS
,  ||| S:209 E:211 ||| ,
transcription  ||| S:211 E:233 ||| JJ
factors ||| S:233 E:240 ||| NNS
,  ||| S:240 E:242 ||| ,
and  ||| S:242 E:246 ||| CC
signaling  ||| S:246 E:256 ||| VBG
proteins  ||| S:256 E:265 ||| NNS
( ||| S:265 E:266 ||| -LRB-
reviewed  ||| S:266 E:275 ||| VBN
in  ||| S:275 E:278 ||| IN
ref.  ||| S:278 E:283 ||| NNP
[  ||| S:283 E:285 ||| -LRB-
1 ||| S:285 E:286 ||| LS
] ||| S:286 E:287 ||| -RRB-
) ||| S:287 E:288 ||| -RRB-
.  ||| S:288 E:298 ||| .
Among  ||| S:298 E:304 ||| IN
the  ||| S:304 E:308 ||| DT
best  ||| S:308 E:313 ||| RBS
studied  ||| S:313 E:321 ||| JJ
examples  ||| S:321 E:330 ||| NNS
of  ||| S:330 E:333 ||| IN
cullin ||| S:333 E:339 ||| JJ
/ ||| S:339 E:340 ||| NNP
RING  ||| S:340 E:345 ||| NNP
enzymes  ||| S:345 E:353 ||| NNS
are  ||| S:353 E:365 ||| VBP
the  ||| S:365 E:369 ||| DT
so-called  ||| S:369 E:379 ||| JJ
SCF  ||| S:379 E:383 ||| NN
complexes ||| S:383 E:392 ||| NNS
.  ||| S:392 E:394 ||| .
SCF  ||| S:394 E:398 ||| NNP
complexes  ||| S:398 E:408 ||| JJ
share  ||| S:408 E:414 ||| NN
homologues  ||| S:414 E:433 ||| NN
of  ||| S:433 E:436 ||| IN
the  ||| S:436 E:440 ||| DT
core  ||| S:440 E:445 ||| NN
components  ||| S:445 E:456 ||| NNS
cullin  ||| S:456 E:463 ||| VBD
1  ||| S:463 E:465 ||| CD
( ||| S:465 E:466 ||| -LRB-
CUL1 ||| S:466 E:470 ||| NNP
) ||| S:470 E:471 ||| -RRB-
,  ||| S:471 E:473 ||| ,
SKP1 ||| S:473 E:477 ||| NNP
,  ||| S:477 E:479 ||| ,
and  ||| S:479 E:483 ||| CC
the  ||| S:483 E:487 ||| DT
RING  ||| S:487 E:500 ||| FW
domain  ||| S:500 E:507 ||| FW
protein  ||| S:507 E:515 ||| FW
HRT1 ||| S:515 E:519 ||| FW
/ ||| S:519 E:520 ||| FW
RBX1 ||| S:520 E:524 ||| FW
/ ||| S:524 E:525 ||| FW
ROC1 ||| S:525 E:529 ||| FW
,  ||| S:529 E:531 ||| ,
which  ||| S:531 E:537 ||| WDT
associate  ||| S:537 E:547 ||| VBP
with  ||| S:547 E:560 ||| IN
different  ||| S:560 E:570 ||| JJ
F-box  ||| S:570 E:576 ||| JJ
proteins  ||| S:576 E:585 ||| NNS
and  ||| S:585 E:589 ||| CC
ubiquitin-conjugating  ||| S:589 E:611 ||| JJ
enzymes  ||| S:611 E:627 ||| NNS
[  ||| S:627 E:629 ||| -LRB-
1 ||| S:629 E:630 ||| LS
] ||| S:630 E:631 ||| -RRB-
.  ||| S:631 E:633 ||| .
F-box  ||| S:633 E:639 ||| JJ
proteins  ||| S:639 E:648 ||| NNS
specifically  ||| S:648 E:661 ||| RB
bind  ||| S:661 E:666 ||| JJ
substrates ||| S:666 E:676 ||| NN
,  ||| S:676 E:686 ||| ,
following  ||| S:686 E:696 ||| VBG
their  ||| S:696 E:702 ||| PRP$
phosphorylation  ||| S:702 E:718 ||| NN
in  ||| S:718 E:721 ||| IN
response  ||| S:721 E:730 ||| NN
to  ||| S:730 E:733 ||| TO
activation  ||| S:733 E:752 ||| VB
of  ||| S:752 E:755 ||| IN
various  ||| S:755 E:763 ||| JJ
signaling  ||| S:763 E:773 ||| JJ
pathways ||| S:773 E:781 ||| NN
.  ||| S:781 E:783 ||| .
Although  ||| S:783 E:792 ||| IN
substrate  ||| S:792 E:810 ||| JJ
phosphorylation  ||| S:810 E:826 ||| NN
is  ||| S:826 E:829 ||| VBZ
one  ||| S:829 E:833 ||| CD
major  ||| S:833 E:839 ||| JJ
determinant  ||| S:839 E:851 ||| NN
of  ||| S:851 E:854 ||| IN
SCF-mediated  ||| S:854 E:875 ||| JJ
ubiquitylation  ||| S:875 E:890 ||| NNS
[  ||| S:890 E:892 ||| -LRB-
1 ||| S:892 E:893 ||| LS
] ||| S:893 E:894 ||| -RRB-
,  ||| S:894 E:896 ||| ,
covalent  ||| S:896 E:905 ||| JJ
modification  ||| S:905 E:918 ||| NN
of  ||| S:918 E:921 ||| IN
the  ||| S:921 E:925 ||| DT
CUL1  ||| S:925 E:938 ||| JJ
subunit  ||| S:938 E:946 ||| NN
through  ||| S:946 E:954 ||| IN
attachment  ||| S:954 E:965 ||| NN
of  ||| S:965 E:968 ||| IN
the  ||| S:968 E:972 ||| DT
ubiquitin-related  ||| S:972 E:990 ||| JJ
peptide  ||| S:990 E:1006 ||| NNS
NEDD8  ||| S:1006 E:1012 ||| VBP
also  ||| S:1012 E:1017 ||| RB
regulates  ||| S:1017 E:1027 ||| VBZ
SCF  ||| S:1027 E:1031 ||| NNP
activity ||| S:1031 E:1039 ||| NN
.  ||| S:1039 E:1041 ||| .
NEDD8  ||| S:1041 E:1047 ||| FW
modification  ||| S:1047 E:1068 ||| FW
stimulates  ||| S:1068 E:1079 ||| FW
SCF-dependent  ||| S:1079 E:1093 ||| FW
substrate  ||| S:1093 E:1103 ||| FW
ubiquitylation  ||| S:1103 E:1127 ||| FW
in  ||| S:1127 E:1130 ||| FW
vitro  ||| S:1130 E:1136 ||| FW
[  ||| S:1136 E:1138 ||| -LRB-
2 ||| S:1138 E:1139 ||| LS
,  ||| S:1139 E:1141 ||| ,
3 ||| S:1141 E:1142 ||| CD
,  ||| S:1142 E:1144 ||| ,
4 ||| S:1144 E:1145 ||| LS
] ||| S:1145 E:1146 ||| -RRB-
,  ||| S:1146 E:1148 ||| ,
and  ||| S:1148 E:1152 ||| CC
mutant  ||| S:1152 E:1159 ||| CD
CUL1  ||| S:1159 E:1172 ||| CD
resistant  ||| S:1172 E:1182 ||| JJ
to  ||| S:1182 E:1185 ||| TO
NEDD8  ||| S:1185 E:1191 ||| CD
modification  ||| S:1191 E:1204 ||| NN
is  ||| S:1204 E:1207 ||| VBZ
defective  ||| S:1207 E:1226 ||| JJ
in  ||| S:1226 E:1229 ||| IN
vivo  ||| S:1229 E:1234 ||| NNS
[  ||| S:1234 E:1236 ||| -LRB-
5 ||| S:1236 E:1237 ||| LS
] ||| S:1237 E:1238 ||| -RRB-
.  ||| S:1238 E:1240 ||| .
In  ||| S:1240 E:1243 ||| IN
addition ||| S:1243 E:1251 ||| NN
,  ||| S:1251 E:1253 ||| ,
fission  ||| S:1253 E:1269 ||| JJ
yeast  ||| S:1269 E:1275 ||| NN
mutants  ||| S:1275 E:1283 ||| NN
deficient  ||| S:1283 E:1293 ||| NN
in  ||| S:1293 E:1296 ||| IN
the  ||| S:1296 E:1300 ||| DT
enzymes  ||| S:1300 E:1308 ||| NN
that  ||| S:1308 E:1313 ||| IN
attach  ||| S:1313 E:1320 ||| CD
Ned8p ||| S:1320 E:1325 ||| CD
,  ||| S:1325 E:1335 ||| ,
or  ||| S:1335 E:1338 ||| CC
in  ||| S:1338 E:1341 ||| IN
the  ||| S:1341 E:1354 ||| DT
ned8  ||| S:1354 E:1359 ||| JJ
gene  ||| S:1359 E:1364 ||| NN
itself ||| S:1364 E:1370 ||| PRP
,  ||| S:1370 E:1372 ||| ,
are  ||| S:1372 E:1376 ||| VBP
inviable  ||| S:1376 E:1385 ||| NNS
[  ||| S:1385 E:1395 ||| -LRB-
5 ||| S:1395 E:1396 ||| LS
] ||| S:1396 E:1397 ||| -RRB-
.  ||| S:1397 E:1407 ||| .
In  ||| S:1407 E:1410 ||| IN
addition  ||| S:1410 E:1419 ||| NN
to  ||| S:1419 E:1422 ||| TO
CUL1 ||| S:1422 E:1426 ||| CD
,  ||| S:1426 E:1428 ||| ,
the  ||| S:1428 E:1432 ||| DT
human  ||| S:1432 E:1438 ||| JJ
genome  ||| S:1438 E:1445 ||| NN
contains  ||| S:1445 E:1454 ||| VBZ
at  ||| S:1454 E:1457 ||| IN
least  ||| S:1457 E:1471 ||| JJS
five  ||| S:1471 E:1476 ||| CD
other  ||| S:1476 E:1482 ||| JJ
cullins ||| S:1482 E:1489 ||| NN
,  ||| S:1489 E:1491 ||| ,
CUL  ||| S:1491 E:1495 ||| NNP
2 ||| S:1495 E:1496 ||| CD
,  ||| S:1496 E:1498 ||| ,
3 ||| S:1498 E:1499 ||| CD
,  ||| S:1499 E:1501 ||| ,
4A ||| S:1501 E:1503 ||| NNP
,  ||| S:1503 E:1505 ||| ,
4B ||| S:1505 E:1507 ||| NNP
,  ||| S:1507 E:1509 ||| ,
and  ||| S:1509 E:1513 ||| CC
5 ||| S:1513 E:1514 ||| CD
.  ||| S:1514 E:1516 ||| .
This  ||| S:1516 E:1521 ||| DT
diversity  ||| S:1521 E:1539 ||| NN
is  ||| S:1539 E:1542 ||| VBZ
partially  ||| S:1542 E:1552 ||| RB
recapitulated  ||| S:1552 E:1566 ||| VBN
in  ||| S:1566 E:1578 ||| IN
S.  ||| S:1578 E:1581 ||| NNP
pombe  ||| S:1581 E:1587 ||| NN
,  ||| S:1587 E:1589 ||| ,
which  ||| S:1589 E:1595 ||| WDT
encodes  ||| S:1595 E:1612 ||| VBZ
pcu3  ||| S:1612 E:1617 ||| NNP
and  ||| S:1617 E:1630 ||| CC
pcu4  ||| S:1630 E:1635 ||| NNP
,  ||| S:1635 E:1637 ||| ,
homologues  ||| S:1637 E:1648 ||| VBG
of  ||| S:1648 E:1651 ||| IN
human  ||| S:1651 E:1657 ||| JJ
CUL3  ||| S:1657 E:1662 ||| NN
and  ||| S:1662 E:1674 ||| CC
CUL4 ||| S:1674 E:1678 ||| NNP
,  ||| S:1678 E:1680 ||| ,
for  ||| S:1680 E:1684 ||| IN
which  ||| S:1684 E:1690 ||| WDT
there  ||| S:1690 E:1696 ||| EX
are  ||| S:1696 E:1700 ||| VBP
no  ||| S:1700 E:1703 ||| DT
direct  ||| S:1703 E:1710 ||| JJ
correlates  ||| S:1710 E:1721 ||| NN
in  ||| S:1721 E:1724 ||| IN
budding  ||| S:1724 E:1740 ||| VBG
yeast  ||| S:1740 E:1746 ||| NN
[  ||| S:1746 E:1748 ||| -LRB-
6 ||| S:1748 E:1749 ||| CD
] ||| S:1749 E:1750 ||| -RRB-
.  ||| S:1750 E:1752 ||| .
All  ||| S:1752 E:1756 ||| DT
human  ||| S:1756 E:1762 ||| JJ
cullins  ||| S:1762 E:1770 ||| JJ
interact  ||| S:1770 E:1779 ||| NN
with  ||| S:1779 E:1784 ||| IN
HRT1 ||| S:1784 E:1788 ||| CD
/ ||| S:1788 E:1789 ||| CD
RBX1 ||| S:1789 E:1793 ||| CD
/ ||| S:1793 E:1794 ||| CD
ROC1  ||| S:1794 E:1807 ||| CD
[  ||| S:1807 E:1809 ||| -LRB-
7 ||| S:1809 E:1810 ||| CD
] ||| S:1810 E:1811 ||| -RRB-
,  ||| S:1811 E:1813 ||| ,
are  ||| S:1813 E:1817 ||| VBP
modified  ||| S:1817 E:1826 ||| VBN
by  ||| S:1826 E:1829 ||| IN
NEDD8  ||| S:1829 E:1835 ||| NNP
[  ||| S:1835 E:1837 ||| -LRB-
8 ||| S:1837 E:1838 ||| CD
] ||| S:1838 E:1839 ||| -RRB-
,  ||| S:1839 E:1841 ||| ,
and  ||| S:1841 E:1845 ||| CC
have  ||| S:1845 E:1850 ||| VBP
ubiquitin  ||| S:1850 E:1860 ||| JJ
ligase  ||| S:1860 E:1875 ||| JJ
activity  ||| S:1875 E:1893 ||| NN
in  ||| S:1893 E:1896 ||| IN
vitro  ||| S:1896 E:1902 ||| NNS
[  ||| S:1902 E:1904 ||| -LRB-
9 ||| S:1904 E:1905 ||| CD
] ||| S:1905 E:1906 ||| -RRB-
.  ||| S:1906 E:1908 ||| .
Similarly ||| S:1908 E:1917 ||| RB
,  ||| S:1917 E:1919 ||| ,
the  ||| S:1919 E:1923 ||| DT
fission  ||| S:1923 E:1939 ||| JJ
yeast  ||| S:1939 E:1945 ||| NN
cullins  ||| S:1945 E:1953 ||| VBD
Pcu1p  ||| S:1953 E:1959 ||| CD
and  ||| S:1959 E:1963 ||| CC
Pcu4p  ||| S:1963 E:1969 ||| NNP
are  ||| S:1969 E:1973 ||| VBP
neddylated ||| S:1973 E:1983 ||| VBN
,  ||| S:1983 E:1985 ||| ,
and  ||| S:1985 E:1997 ||| CC
neddylation  ||| S:1997 E:2009 ||| NN
is  ||| S:2009 E:2012 ||| VBZ
critical  ||| S:2012 E:2021 ||| JJ
for  ||| S:2021 E:2025 ||| IN
their  ||| S:2025 E:2031 ||| PRP$
function  ||| S:2031 E:2049 ||| NN
in  ||| S:2049 E:2052 ||| IN
vivo  ||| S:2052 E:2057 ||| NN
.  ||| S:2057 E:2059 ||| .
[  ||| S:2059 E:2061 ||| -LRB-
5 ||| S:2061 E:2062 ||| LS
] ||| S:2062 E:2063 ||| -RRB-
.  ||| S:2063 E:2073 ||| .
While  ||| S:2073 E:2079 ||| IN
it  ||| S:2079 E:2082 ||| PRP
is  ||| S:2082 E:2085 ||| VBZ
clear  ||| S:2085 E:2091 ||| JJ
that  ||| S:2091 E:2096 ||| IN
neddylation  ||| S:2096 E:2108 ||| NN
affects  ||| S:2108 E:2116 ||| VBZ
the  ||| S:2116 E:2120 ||| DT
activity  ||| S:2120 E:2137 ||| NN
of  ||| S:2137 E:2140 ||| IN
cullin ||| S:2140 E:2146 ||| JJ
/ ||| S:2146 E:2147 ||| NNP
RING  ||| S:2147 E:2152 ||| NNP
complexes ||| S:2152 E:2161 ||| NNS
,  ||| S:2161 E:2163 ||| ,
mechanisms  ||| S:2163 E:2174 ||| NNS
controlling  ||| S:2174 E:2186 ||| VBG
this  ||| S:2186 E:2199 ||| DT
modification  ||| S:2199 E:2212 ||| NN
are  ||| S:2212 E:2216 ||| VBP
just  ||| S:2216 E:2221 ||| RB
emerging ||| S:2221 E:2229 ||| VBG
.  ||| S:2229 E:2231 ||| .
A  ||| S:2231 E:2233 ||| DT
recent  ||| S:2233 E:2240 ||| JJ
study  ||| S:2240 E:2246 ||| NN
by  ||| S:2246 E:2249 ||| IN
Lyapina  ||| S:2249 E:2266 ||| NNP
et  ||| S:2266 E:2269 ||| NNP
al.  ||| S:2269 E:2273 ||| NNP
uncovered  ||| S:2273 E:2283 ||| VBD
a  ||| S:2283 E:2285 ||| DT
novel  ||| S:2285 E:2291 ||| NN
connection  ||| S:2291 E:2310 ||| NN
between  ||| S:2310 E:2318 ||| IN
the  ||| S:2318 E:2322 ||| DT
COP9 ||| S:2322 E:2326 ||| CD
/ ||| S:2326 E:2327 ||| CD
signalosome  ||| S:2327 E:2339 ||| NNS
( ||| S:2339 E:2340 ||| -LRB-
CSN ||| S:2340 E:2343 ||| NNP
)  ||| S:2343 E:2345 ||| -RRB-
and  ||| S:2345 E:2349 ||| CC
cullin  ||| S:2349 E:2356 ||| JJ
neddylation  ||| S:2356 E:2368 ||| NNS
[  ||| S:2368 E:2378 ||| -LRB-
10 ||| S:2378 E:2380 ||| CD
] ||| S:2380 E:2381 ||| -RRB-
.  ||| S:2381 E:2383 ||| .
CSN  ||| S:2383 E:2387 ||| NNP
is  ||| S:2387 E:2390 ||| VBZ
a  ||| S:2390 E:2392 ||| DT
highly  ||| S:2392 E:2399 ||| RB
conserved  ||| S:2399 E:2409 ||| JJ
multiprotein  ||| S:2409 E:2422 ||| JJ
complex  ||| S:2422 E:2438 ||| NN
consisting  ||| S:2438 E:2449 ||| VBG
of  ||| S:2449 E:2452 ||| IN
eight  ||| S:2452 E:2458 ||| CD
subunits ||| S:2458 E:2466 ||| NN
,  ||| S:2466 E:2468 ||| ,
which  ||| S:2468 E:2474 ||| WDT
have  ||| S:2474 E:2479 ||| VBP
been  ||| S:2479 E:2484 ||| VBN
implicated  ||| S:2484 E:2495 ||| VBN
in  ||| S:2495 E:2506 ||| IN
a  ||| S:2506 E:2508 ||| DT
wide  ||| S:2508 E:2513 ||| JJ
variety  ||| S:2513 E:2521 ||| NN
of  ||| S:2521 E:2524 ||| IN
regulatory  ||| S:2524 E:2535 ||| JJ
processes ||| S:2535 E:2544 ||| NNS
,  ||| S:2544 E:2546 ||| ,
including ||| S:2546 E:2555 ||| VBG
,  ||| S:2555 E:2557 ||| ,
cell  ||| S:2557 E:2570 ||| NN
cycle  ||| S:2570 E:2576 ||| NN
control  ||| S:2576 E:2584 ||| NN
[  ||| S:2584 E:2586 ||| -LRB-
11 ||| S:2586 E:2588 ||| CD
,  ||| S:2588 E:2590 ||| ,
12 ||| S:2590 E:2592 ||| CD
] ||| S:2592 E:2593 ||| -RRB-
,  ||| S:2593 E:2595 ||| ,
signal  ||| S:2595 E:2602 ||| NN
transduction  ||| S:2602 E:2615 ||| NNS
[  ||| S:2615 E:2617 ||| -LRB-
13 ||| S:2617 E:2619 ||| CD
] ||| S:2619 E:2620 ||| -RRB-
,  ||| S:2620 E:2630 ||| ,
transcriptional  ||| S:2630 E:2646 ||| FW
activation  ||| S:2646 E:2657 ||| FW
[  ||| S:2657 E:2659 ||| -LRB-
14 ||| S:2659 E:2661 ||| CD
] ||| S:2661 E:2662 ||| -RRB-
,  ||| S:2662 E:2664 ||| ,
and  ||| S:2664 E:2668 ||| CC
plant  ||| S:2668 E:2682 ||| NN
photomorphogenesis  ||| S:2682 E:2701 ||| NNS
[  ||| S:2701 E:2703 ||| -LRB-
15 ||| S:2703 E:2705 ||| CD
,  ||| S:2705 E:2707 ||| ,
16 ||| S:2707 E:2709 ||| CD
] ||| S:2709 E:2710 ||| -RRB-
.  ||| S:2710 E:2712 ||| .
To  ||| S:2712 E:2715 ||| TO
date ||| S:2715 E:2719 ||| NN
,  ||| S:2719 E:2721 ||| ,
no  ||| S:2721 E:2724 ||| DT
distinct  ||| S:2724 E:2741 ||| JJ
biochemical  ||| S:2741 E:2753 ||| JJ
activity  ||| S:2753 E:2762 ||| NN
has  ||| S:2762 E:2766 ||| VBZ
been  ||| S:2766 E:2771 ||| VBN
identified  ||| S:2771 E:2782 ||| VBN
that  ||| S:2782 E:2787 ||| WDT
can  ||| S:2787 E:2791 ||| MD
reconcile  ||| S:2791 E:2809 ||| VB
this  ||| S:2809 E:2814 ||| DT
diversity  ||| S:2814 E:2824 ||| NN
in  ||| S:2824 E:2827 ||| IN
CSN  ||| S:2827 E:2831 ||| NNP
functions ||| S:2831 E:2840 ||| NNS
.  ||| S:2840 E:2842 ||| .
The  ||| S:2842 E:2846 ||| DT
eight  ||| S:2846 E:2852 ||| CD
CSN  ||| S:2852 E:2856 ||| NN
subunits  ||| S:2856 E:2873 ||| NNS
show  ||| S:2873 E:2878 ||| VBP
a  ||| S:2878 E:2880 ||| DT
one-to-one  ||| S:2880 E:2891 ||| JJ
relationship  ||| S:2891 E:2904 ||| NN
to  ||| S:2904 E:2907 ||| TO
components  ||| S:2907 E:2918 ||| NNS
of  ||| S:2918 E:2921 ||| IN
the  ||| S:2921 E:2925 ||| DT
19S  ||| S:2925 E:2937 ||| FW
proteasome  ||| S:2937 E:2948 ||| FW
lid  ||| S:2948 E:2952 ||| FW
complex  ||| S:2952 E:2960 ||| FW
[  ||| S:2960 E:2962 ||| -LRB-
17 ||| S:2962 E:2964 ||| CD
,  ||| S:2964 E:2966 ||| ,
18 ||| S:2966 E:2968 ||| CD
,  ||| S:2968 E:2970 ||| ,
19 ||| S:2970 E:2972 ||| CD
]  ||| S:2972 E:2974 ||| -RRB-
and ||| S:2974 E:2977 ||| CC
,  ||| S:2977 E:2979 ||| ,
like  ||| S:2979 E:2993 ||| IN
pcu3  ||| S:2993 E:2998 ||| NNP
and  ||| S:2998 E:3011 ||| CC
pcu4  ||| S:3011 E:3016 ||| NNP
,  ||| S:3016 E:3018 ||| ,
at  ||| S:3018 E:3021 ||| IN
least  ||| S:3021 E:3027 ||| JJS
seven  ||| S:3027 E:3033 ||| CD
of  ||| S:3033 E:3036 ||| IN
the  ||| S:3036 E:3040 ||| DT
eight  ||| S:3040 E:3054 ||| CD
human  ||| S:3054 E:3060 ||| JJ
subunits  ||| S:3060 E:3069 ||| NNS
are  ||| S:3069 E:3073 ||| VBP
conserved  ||| S:3073 E:3083 ||| VBN
in  ||| S:3083 E:3086 ||| IN
fission  ||| S:3086 E:3094 ||| JJ
yeast ||| S:3094 E:3099 ||| NN
,  ||| S:3099 E:3101 ||| ,
but  ||| S:3101 E:3105 ||| CC
not  ||| S:3105 E:3109 ||| RB
in  ||| S:3109 E:3120 ||| IN
budding  ||| S:3120 E:3128 ||| VBG
yeast.  ||| S:3128 E:3135 ||| NNP
[  ||| S:3135 E:3137 ||| -LRB-
16 ||| S:3137 E:3139 ||| CD
,  ||| S:3139 E:3141 ||| ,
20 ||| S:3141 E:3143 ||| CD
] ||| S:3143 E:3144 ||| -RRB-
.  ||| S:3144 E:3154 ||| .
Lyapina  ||| S:3154 E:3171 ||| NNP
et  ||| S:3171 E:3174 ||| NNP
al.  ||| S:3174 E:3178 ||| NNP
recently  ||| S:3178 E:3187 ||| RB
showed  ||| S:3187 E:3194 ||| VBD
that  ||| S:3194 E:3207 ||| DT
disruption  ||| S:3207 E:3218 ||| NN
of  ||| S:3218 E:3230 ||| IN
S.  ||| S:3230 E:3233 ||| NNP
pombe  ||| S:3233 E:3239 ||| VBD
CSN  ||| S:3239 E:3243 ||| NNP
subunit  ||| S:3243 E:3251 ||| VBD
1  ||| S:3251 E:3253 ||| CD
(  ||| S:3253 E:3264 ||| -LRB-
caa1 ||| S:3264 E:3268 ||| CD
/ ||| S:3268 E:3269 ||| CD
csn1  ||| S:3269 E:3274 ||| CD
)  ||| S:3274 E:3276 ||| -RRB-
results  ||| S:3276 E:3284 ||| NNS
in  ||| S:3284 E:3287 ||| IN
accumulation  ||| S:3287 E:3308 ||| NN
of  ||| S:3308 E:3311 ||| IN
Pcu1p  ||| S:3311 E:3317 ||| CD
in  ||| S:3317 E:3320 ||| IN
the  ||| S:3320 E:3324 ||| DT
neddylated  ||| S:3324 E:3335 ||| JJ
state  ||| S:3335 E:3341 ||| NN
[  ||| S:3341 E:3343 ||| -LRB-
10 ||| S:3343 E:3345 ||| CD
] ||| S:3345 E:3346 ||| -RRB-
.  ||| S:3346 E:3348 ||| .
However ||| S:3348 E:3355 ||| RB
,  ||| S:3355 E:3357 ||| ,
it  ||| S:3357 E:3368 ||| PRP
remained  ||| S:3368 E:3377 ||| VBD
unclear  ||| S:3377 E:3385 ||| JJ
whether  ||| S:3385 E:3393 ||| IN
this  ||| S:3393 E:3398 ||| DT
reflects  ||| S:3398 E:3407 ||| VBZ
global  ||| S:3407 E:3414 ||| JJ
control  ||| S:3414 E:3422 ||| NN
of  ||| S:3422 E:3433 ||| IN
multiple  ||| S:3433 E:3442 ||| JJ
cullins  ||| S:3442 E:3450 ||| NN
by  ||| S:3450 E:3453 ||| IN
Csn1p  ||| S:3453 E:3459 ||| CD
as  ||| S:3459 E:3462 ||| IN
part  ||| S:3462 E:3467 ||| NN
of  ||| S:3467 E:3470 ||| IN
the  ||| S:3470 E:3474 ||| DT
entire  ||| S:3474 E:3481 ||| JJ
CSN  ||| S:3481 E:3493 ||| NNP
complex ||| S:3493 E:3500 ||| NN
.  ||| S:3500 E:3502 ||| .
We  ||| S:3502 E:3505 ||| PRP
have  ||| S:3505 E:3510 ||| VBP
examined  ||| S:3510 E:3519 ||| VBN
this  ||| S:3519 E:3524 ||| DT
question  ||| S:3524 E:3533 ||| NN
by  ||| S:3533 E:3536 ||| IN
determining  ||| S:3536 E:3548 ||| VBG
the  ||| S:3548 E:3560 ||| DT
effect  ||| S:3560 E:3567 ||| NN
of  ||| S:3567 E:3570 ||| IN
disruption  ||| S:3570 E:3581 ||| NN
of  ||| S:3581 E:3584 ||| IN
several  ||| S:3584 E:3592 ||| JJ
CSN  ||| S:3592 E:3596 ||| NNP
subunits  ||| S:3596 E:3605 ||| NN
on  ||| S:3605 E:3608 ||| IN
Pcu3p  ||| S:3608 E:3622 ||| CD
neddylation ||| S:3622 E:3633 ||| NN
,  ||| S:3633 E:3635 ||| ,
localization ||| S:3635 E:3647 ||| NN
,  ||| S:3647 E:3649 ||| ,
and  ||| S:3649 E:3653 ||| CC
ubiquitin  ||| S:3653 E:3663 ||| JJ
ligase  ||| S:3663 E:3670 ||| JJ
activity ||| S:3670 E:3678 ||| NN
.  ||| S:3678 E:3688 ||| .
Our  ||| S:3688 E:3692 ||| PRP$
results  ||| S:3692 E:3700 ||| NNS
indicate  ||| S:3700 E:3709 ||| VBP
that  ||| S:3709 E:3714 ||| IN
the  ||| S:3714 E:3718 ||| DT
entire  ||| S:3718 E:3725 ||| JJ
CSN  ||| S:3725 E:3729 ||| NNP
complex  ||| S:3729 E:3737 ||| NN
is  ||| S:3737 E:3748 ||| VBZ
required  ||| S:3748 E:3757 ||| VBN
for  ||| S:3757 E:3761 ||| IN
proper  ||| S:3761 E:3768 ||| JJ
control  ||| S:3768 E:3776 ||| NN
of  ||| S:3776 E:3779 ||| IN
the  ||| S:3779 E:3783 ||| DT
neddylation  ||| S:3783 E:3795 ||| JJ
state  ||| S:3795 E:3801 ||| NN
of  ||| S:3801 E:3812 ||| IN
multiple  ||| S:3812 E:3821 ||| JJ
cullins ||| S:3821 E:3828 ||| NN
.  ||| S:3828 E:3852 ||| .
Results  ||| S:3852 E:3879 ||| NNS
Pcu3p  ||| S:3879 E:3885 ||| RB
is  ||| S:3885 E:3888 ||| VBZ
modified  ||| S:3888 E:3897 ||| VBN
by  ||| S:3897 E:3900 ||| IN
Ned8p  ||| S:3900 E:3916 ||| NNP
Immunoblotting  ||| S:3916 E:3931 ||| NNP
of  ||| S:3931 E:3934 ||| IN
protein  ||| S:3934 E:3942 ||| NN
lysates  ||| S:3942 E:3950 ||| VBZ
prepared  ||| S:3950 E:3959 ||| VBN
from  ||| S:3959 E:3975 ||| IN
S.  ||| S:3975 E:3978 ||| NNP
pombe  ||| S:3978 E:3984 ||| NN
cells ||| S:3984 E:3989 ||| NNS
,  ||| S:3989 E:3991 ||| ,
whose  ||| S:3991 E:4008 ||| WP$
pcu3  ||| S:4008 E:4013 ||| CD
chromosomal  ||| S:4013 E:4025 ||| CD
locus  ||| S:4025 E:4031 ||| NNS
was  ||| S:4031 E:4035 ||| VBD
modified  ||| S:4035 E:4054 ||| VBN
to  ||| S:4054 E:4057 ||| TO
encode  ||| S:4057 E:4064 ||| CD
Pcu3p  ||| S:4064 E:4070 ||| CD
with  ||| S:4070 E:4075 ||| IN
thirteen  ||| S:4075 E:4084 ||| JJ
copies  ||| S:4084 E:4091 ||| NNS
of  ||| S:4091 E:4094 ||| IN
the  ||| S:4094 E:4098 ||| DT
Myc  ||| S:4098 E:4102 ||| NNP
epitope  ||| S:4102 E:4120 ||| VBD
attached  ||| S:4120 E:4129 ||| VBN
to  ||| S:4129 E:4132 ||| TO
its  ||| S:4132 E:4136 ||| PRP$
C-terminus ||| S:4136 E:4146 ||| JJ
,  ||| S:4146 E:4148 ||| ,
revealed  ||| S:4148 E:4157 ||| VBD
two  ||| S:4157 E:4161 ||| CD
distinct  ||| S:4161 E:4170 ||| JJ
species  ||| S:4170 E:4188 ||| NNS
of  ||| S:4188 E:4191 ||| IN
Pcu3p ||| S:4191 E:4196 ||| NNP
,  ||| S:4196 E:4198 ||| ,
which  ||| S:4198 E:4204 ||| WDT
migrated  ||| S:4204 E:4213 ||| VBZ
on  ||| S:4213 E:4216 ||| IN
SDS  ||| S:4216 E:4220 ||| NNP
gels  ||| S:4220 E:4225 ||| NN
as  ||| S:4225 E:4228 ||| IN
two  ||| S:4228 E:4232 ||| CD
closely  ||| S:4232 E:4250 ||| RB
spaced  ||| S:4250 E:4257 ||| JJ
species  ||| S:4257 E:4265 ||| NNS
of  ||| S:4265 E:4268 ||| IN
roughly  ||| S:4268 E:4276 ||| RB
equal  ||| S:4276 E:4282 ||| JJ
abundance  ||| S:4282 E:4292 ||| NNS
( ||| S:4292 E:4293 ||| -LRB-
Fig.  ||| S:4293 E:4298 ||| NNP
1A ||| S:4298 E:4300 ||| NNP
) ||| S:4300 E:4301 ||| -RRB-
.  ||| S:4301 E:4313 ||| .
Several  ||| S:4313 E:4321 ||| JJ
findings  ||| S:4321 E:4330 ||| NNS
indicate  ||| S:4330 E:4339 ||| VBP
that  ||| S:4339 E:4344 ||| IN
the  ||| S:4344 E:4348 ||| DT
slower  ||| S:4348 E:4355 ||| JJR
migrating  ||| S:4355 E:4365 ||| JJ
form  ||| S:4365 E:4380 ||| NN
of  ||| S:4380 E:4383 ||| IN
Pcu3p  ||| S:4383 E:4389 ||| NNP
arose  ||| S:4389 E:4395 ||| VBD
from  ||| S:4395 E:4400 ||| IN
covalent  ||| S:4400 E:4409 ||| JJ
modification  ||| S:4409 E:4422 ||| NN
with  ||| S:4422 E:4427 ||| IN
the  ||| S:4427 E:4441 ||| DT
ubiquitin-related  ||| S:4441 E:4459 ||| JJ
protein  ||| S:4459 E:4467 ||| NN
Ned8p ||| S:4467 E:4472 ||| NN
:  ||| S:4472 E:4474 ||| :
First ||| S:4474 E:4479 ||| NNP
,  ||| S:4479 E:4481 ||| ,
overexpression  ||| S:4481 E:4496 ||| VBG
of  ||| S:4496 E:4509 ||| IN
a  ||| S:4509 E:4511 ||| DT
fusion  ||| S:4511 E:4518 ||| NN
protein  ||| S:4518 E:4526 ||| NN
of  ||| S:4526 E:4529 ||| IN
Ned8p  ||| S:4529 E:4535 ||| NNP
and  ||| S:4535 E:4539 ||| CC
glutathione  ||| S:4539 E:4551 ||| JJ
transferase  ||| S:4551 E:4573 ||| NNS
( ||| S:4573 E:4574 ||| -LRB-
GST-Ned8p ||| S:4574 E:4583 ||| NNP
)  ||| S:4583 E:4585 ||| -RRB-
converted  ||| S:4585 E:4595 ||| VBD
the  ||| S:4595 E:4599 ||| DT
faster ||| S:4599 E:4605 ||| RBR
,  ||| S:4605 E:4607 ||| ,
unmodified  ||| S:4607 E:4618 ||| JJ
form  ||| S:4618 E:4623 ||| NN
of  ||| S:4623 E:4636 ||| IN
Pcu3p  ||| S:4636 E:4642 ||| CD
into  ||| S:4642 E:4647 ||| IN
a  ||| S:4647 E:4649 ||| DT
high  ||| S:4649 E:4654 ||| JJ
molecular  ||| S:4654 E:4664 ||| JJ
weight  ||| S:4664 E:4671 ||| NN
species  ||| S:4671 E:4679 ||| NNS
that  ||| S:4679 E:4684 ||| WDT
reacted  ||| S:4684 E:4702 ||| VBD
with  ||| S:4702 E:4707 ||| IN
antibodies  ||| S:4707 E:4718 ||| NNS
to  ||| S:4718 E:4721 ||| TO
GST  ||| S:4721 E:4725 ||| NNP
( ||| S:4725 E:4726 ||| -LRB-
Fig.  ||| S:4726 E:4731 ||| NNP
1A ||| S:4731 E:4733 ||| NNP
) ||| S:4733 E:4734 ||| -RRB-
.  ||| S:4734 E:4736 ||| .
Second ||| S:4736 E:4742 ||| LS
,  ||| S:4742 E:4744 ||| ,
replacing  ||| S:4744 E:4764 ||| VBG
lysine  ||| S:4764 E:4771 ||| CD
729 ||| S:4771 E:4774 ||| CD
,  ||| S:4774 E:4776 ||| ,
which  ||| S:4776 E:4782 ||| WDT
is  ||| S:4782 E:4785 ||| VBZ
homologous  ||| S:4785 E:4796 ||| VBN
to  ||| S:4796 E:4799 ||| TO
the  ||| S:4799 E:4803 ||| DT
conserved  ||| S:4803 E:4823 ||| JJ
neddylation  ||| S:4823 E:4835 ||| JJ
sites  ||| S:4835 E:4841 ||| NNS
in  ||| S:4841 E:4844 ||| IN
other  ||| S:4844 E:4850 ||| JJ
cullins ||| S:4850 E:4857 ||| NN
,  ||| S:4857 E:4859 ||| ,
with  ||| S:4859 E:4864 ||| IN
arginine ||| S:4864 E:4872 ||| NN
,  ||| S:4872 E:4884 ||| ,
completely  ||| S:4884 E:4895 ||| RB
abolished  ||| S:4895 E:4905 ||| VBN
the  ||| S:4905 E:4909 ||| DT
slower  ||| S:4909 E:4916 ||| JJR
migrating ||| S:4916 E:4925 ||| NN
,  ||| S:4925 E:4927 ||| ,
modified  ||| S:4927 E:4936 ||| VBN
form  ||| S:4936 E:4951 ||| NN
of  ||| S:4951 E:4954 ||| IN
Pcu3p  ||| S:4954 E:4960 ||| NNP
( ||| S:4960 E:4961 ||| -LRB-
Fig.  ||| S:4961 E:4966 ||| NNP
1B ||| S:4966 E:4968 ||| NNP
) ||| S:4968 E:4969 ||| -RRB-
.  ||| S:4969 E:4971 ||| .
In  ||| S:4971 E:4974 ||| IN
contrast ||| S:4974 E:4982 ||| NN
,  ||| S:4982 E:4984 ||| ,
mutation  ||| S:4984 E:4993 ||| NN
of  ||| S:4993 E:4996 ||| IN
a  ||| S:4996 E:5008 ||| DT
neighboring  ||| S:5008 E:5020 ||| JJ
conserved  ||| S:5020 E:5030 ||| JJ
lysine  ||| S:5030 E:5037 ||| NNS
( ||| S:5037 E:5038 ||| -LRB-
residue  ||| S:5038 E:5046 ||| CD
760 ||| S:5046 E:5049 ||| CD
)  ||| S:5049 E:5051 ||| -RRB-
did  ||| S:5051 E:5055 ||| VBD
not  ||| S:5055 E:5059 ||| RB
alter  ||| S:5059 E:5075 ||| VB
the  ||| S:5075 E:5079 ||| DT
mobility  ||| S:5079 E:5088 ||| NN
of  ||| S:5088 E:5091 ||| IN
Pcu3p ||| S:5091 E:5096 ||| CD
.  ||| S:5096 E:5098 ||| .
Thus ||| S:5098 E:5102 ||| RB
,  ||| S:5102 E:5104 ||| ,
as  ||| S:5104 E:5107 ||| RB
with  ||| S:5107 E:5112 ||| IN
other  ||| S:5112 E:5129 ||| JJ
S.  ||| S:5129 E:5132 ||| NNP
pombe  ||| S:5132 E:5138 ||| FW
cullins  ||| S:5138 E:5146 ||| FW
[  ||| S:5146 E:5148 ||| -LRB-
5 ||| S:5148 E:5149 ||| LS
] ||| S:5149 E:5150 ||| -RRB-
,  ||| S:5150 E:5152 ||| ,
Pcu3p  ||| S:5152 E:5168 ||| FW
undergoes  ||| S:5168 E:5178 ||| FW
covalent  ||| S:5178 E:5187 ||| FW
modification  ||| S:5187 E:5200 ||| NN
by  ||| S:5200 E:5203 ||| IN
ubiquitin-like  ||| S:5203 E:5218 ||| JJ
Ned8p  ||| S:5218 E:5234 ||| NN
at  ||| S:5234 E:5237 ||| IN
lysine  ||| S:5237 E:5244 ||| CD
729 ||| S:5244 E:5247 ||| CD
.  ||| S:5247 E:5277 ||| .
Multiple  ||| S:5277 E:5286 ||| FW
csnmutants  ||| S:5286 E:5297 ||| FW
accumulate  ||| S:5297 E:5308 ||| FW
neddylated  ||| S:5308 E:5329 ||| FW
Pcu3p  ||| S:5329 E:5345 ||| FW
Interestingly ||| S:5345 E:5358 ||| NNP
,  ||| S:5358 E:5360 ||| ,
fission  ||| S:5360 E:5368 ||| FW
yeast  ||| S:5368 E:5385 ||| FW
caa1 ||| S:5385 E:5389 ||| FW
/ ||| S:5389 E:5390 ||| FW
csn1  ||| S:5390 E:5395 ||| FW
deletion  ||| S:5395 E:5404 ||| FW
mutants  ||| S:5404 E:5412 ||| FW
show  ||| S:5412 E:5417 ||| VBP
a  ||| S:5417 E:5429 ||| DT
set  ||| S:5429 E:5433 ||| NN
of  ||| S:5433 E:5436 ||| IN
defects ||| S:5436 E:5443 ||| NNS
,  ||| S:5443 E:5445 ||| ,
which  ||| S:5445 E:5451 ||| WDT
partially  ||| S:5451 E:5461 ||| RB
overlaps  ||| S:5461 E:5470 ||| VBN
that  ||| S:5470 E:5475 ||| IN
found  ||| S:5475 E:5481 ||| VBN
in  ||| S:5481 E:5495 ||| IN
pcu3  ||| S:5495 E:5500 ||| CD
disruptants ||| S:5500 E:5511 ||| NNS
:  ||| S:5511 E:5513 ||| :
slow  ||| S:5513 E:5518 ||| JJ
growth ||| S:5518 E:5524 ||| NN
,  ||| S:5524 E:5526 ||| ,
cell  ||| S:5526 E:5541 ||| NN
elongation ||| S:5541 E:5551 ||| NN
,  ||| S:5551 E:5553 ||| ,
and  ||| S:5553 E:5557 ||| CC
sensitivity  ||| S:5557 E:5569 ||| NN
to  ||| S:5569 E:5572 ||| TO
UV-irradiation ||| S:5572 E:5586 ||| JJ
,  ||| S:5586 E:5588 ||| ,
but  ||| S:5588 E:5592 ||| CC
not  ||| S:5592 E:5606 ||| RB
hydroxyurea  ||| S:5606 E:5618 ||| JJ
[  ||| S:5618 E:5620 ||| -LRB-
6 ||| S:5620 E:5621 ||| CD
,  ||| S:5621 E:5623 ||| ,
21 ||| S:5623 E:5625 ||| CD
] ||| S:5625 E:5626 ||| -RRB-
.  ||| S:5626 E:5628 ||| .
With  ||| S:5628 E:5633 ||| IN
respect  ||| S:5633 E:5641 ||| NN
to  ||| S:5641 E:5644 ||| TO
the  ||| S:5644 E:5648 ||| DT
recent  ||| S:5648 E:5665 ||| JJ
implication  ||| S:5665 E:5677 ||| NN
of  ||| S:5677 E:5680 ||| IN
CSN  ||| S:5680 E:5684 ||| NNP
in  ||| S:5684 E:5687 ||| IN
cullin  ||| S:5687 E:5694 ||| JJ
regulation  ||| S:5694 E:5705 ||| NN
[  ||| S:5705 E:5707 ||| -LRB-
10 ||| S:5707 E:5709 ||| CD
] ||| S:5709 E:5710 ||| -RRB-
,  ||| S:5710 E:5712 ||| ,
we  ||| S:5712 E:5725 ||| PRP
considered  ||| S:5725 E:5736 ||| VBD
the  ||| S:5736 E:5740 ||| DT
possibility  ||| S:5740 E:5752 ||| NN
that  ||| S:5752 E:5757 ||| IN
the  ||| S:5757 E:5761 ||| DT
overlapping  ||| S:5761 E:5783 ||| JJ
phenotypes  ||| S:5783 E:5794 ||| NN
of  ||| S:5794 E:5808 ||| IN
csn1  ||| S:5808 E:5813 ||| NNP
and  ||| S:5813 E:5828 ||| CC
pcu3  ||| S:5828 E:5833 ||| CD
mutants  ||| S:5833 E:5841 ||| NNS
could  ||| S:5841 E:5847 ||| MD
arise  ||| S:5847 E:5853 ||| VB
from  ||| S:5853 E:5868 ||| IN
interference  ||| S:5868 E:5881 ||| NN
with  ||| S:5881 E:5886 ||| IN
Pcu3p  ||| S:5886 E:5892 ||| CD
function ||| S:5892 E:5900 ||| NN
.  ||| S:5900 E:5912 ||| .
Initial  ||| S:5912 E:5920 ||| JJ
support  ||| S:5920 E:5928 ||| NN
for  ||| S:5928 E:5932 ||| IN
this  ||| S:5932 E:5937 ||| DT
hypothesis  ||| S:5937 E:5948 ||| NN
was  ||| S:5948 E:5952 ||| VBD
provided  ||| S:5952 E:5961 ||| VBN
by  ||| S:5961 E:5974 ||| IN
the  ||| S:5974 E:5978 ||| DT
observation  ||| S:5978 E:5990 ||| NN
that  ||| S:5990 E:5995 ||| IN
disruption  ||| S:5995 E:6006 ||| NN
of  ||| S:6006 E:6020 ||| IN
csn1  ||| S:6020 E:6025 ||| NNP
led  ||| S:6025 E:6029 ||| VBD
to  ||| S:6029 E:6032 ||| TO
accumulation  ||| S:6032 E:6045 ||| VB
of  ||| S:6045 E:6048 ||| IN
Pcu3p  ||| S:6048 E:6064 ||| CD
in  ||| S:6064 E:6067 ||| IN
the  ||| S:6067 E:6071 ||| DT
slower  ||| S:6071 E:6078 ||| JJR
migrating  ||| S:6078 E:6088 ||| JJ
form  ||| S:6088 E:6093 ||| NN
( ||| S:6093 E:6094 ||| -LRB-
Fig.  ||| S:6094 E:6099 ||| NNP
2A ||| S:6099 E:6101 ||| NNP
) ||| S:6101 E:6102 ||| -RRB-
.  ||| S:6102 E:6104 ||| .
This  ||| S:6104 E:6109 ||| DT
shift  ||| S:6109 E:6115 ||| NN
in  ||| S:6115 E:6128 ||| IN
migration  ||| S:6128 E:6138 ||| NN
is  ||| S:6138 E:6141 ||| VBZ
due  ||| S:6141 E:6145 ||| JJ
to  ||| S:6145 E:6148 ||| TO
Pcu3p  ||| S:6148 E:6154 ||| CD
neddylation  ||| S:6154 E:6166 ||| NNS
as  ||| S:6166 E:6169 ||| RB
shown  ||| S:6169 E:6175 ||| VBN
by  ||| S:6175 E:6188 ||| IN
overexpression  ||| S:6188 E:6203 ||| NN
of  ||| S:6203 E:6206 ||| IN
GST-Ned8p  ||| S:6206 E:6216 ||| CD
in  ||| S:6216 E:6230 ||| IN
csn1  ||| S:6230 E:6235 ||| CD
mutants ||| S:6235 E:6242 ||| NNS
.  ||| S:6242 E:6244 ||| .
This  ||| S:6244 E:6249 ||| DT
caused  ||| S:6249 E:6256 ||| VBN
an  ||| S:6256 E:6269 ||| DT
additional  ||| S:6269 E:6280 ||| JJ
supershift ||| S:6280 E:6290 ||| NN
,  ||| S:6290 E:6292 ||| ,
converting  ||| S:6292 E:6303 ||| VBG
a  ||| S:6303 E:6305 ||| DT
substantial  ||| S:6305 E:6317 ||| JJ
portion  ||| S:6317 E:6335 ||| NN
of  ||| S:6335 E:6338 ||| IN
the  ||| S:6338 E:6342 ||| DT
slower  ||| S:6342 E:6349 ||| JJR
migrating  ||| S:6349 E:6359 ||| JJ
form  ||| S:6359 E:6364 ||| NN
into  ||| S:6364 E:6369 ||| IN
a  ||| S:6369 E:6371 ||| DT
GST-Ned8p  ||| S:6371 E:6381 ||| FW
modified  ||| S:6381 E:6400 ||| FW
species  ||| S:6400 E:6408 ||| FW
( ||| S:6408 E:6409 ||| -LRB-
Fig.  ||| S:6409 E:6414 ||| NNP
2B ||| S:6414 E:6416 ||| NNP
) ||| S:6416 E:6417 ||| -RRB-
.  ||| S:6417 E:6419 ||| .
Importantly ||| S:6419 E:6430 ||| RB
,  ||| S:6430 E:6432 ||| ,
accumulation  ||| S:6432 E:6445 ||| NN
of  ||| S:6445 E:6458 ||| IN
neddylated  ||| S:6458 E:6469 ||| JJ
Pcu3p  ||| S:6469 E:6475 ||| NN
was  ||| S:6475 E:6479 ||| VBD
also  ||| S:6479 E:6484 ||| RB
apparent  ||| S:6484 E:6493 ||| JJ
in  ||| S:6493 E:6496 ||| IN
strains  ||| S:6496 E:6504 ||| NNS
deleted  ||| S:6504 E:6512 ||| VBN
for  ||| S:6512 E:6537 ||| IN
csn3  ||| S:6537 E:6542 ||| NNP
,  ||| S:6542 E:6555 ||| ,
csn4  ||| S:6555 E:6560 ||| NNP
,  ||| S:6560 E:6562 ||| ,
and  ||| S:6562 E:6577 ||| CC
csn5  ||| S:6577 E:6582 ||| NNP
( ||| S:6582 E:6583 ||| -LRB-
Fig.  ||| S:6583 E:6588 ||| NNP
2A ||| S:6588 E:6590 ||| NNP
) ||| S:6590 E:6591 ||| -RRB-
,  ||| S:6591 E:6593 ||| ,
three  ||| S:6593 E:6599 ||| CD
genes  ||| S:6599 E:6615 ||| NNS
encoding  ||| S:6615 E:6624 ||| VBP
other  ||| S:6624 E:6630 ||| JJ
putative  ||| S:6630 E:6639 ||| JJ
subunits  ||| S:6639 E:6648 ||| NN
of  ||| S:6648 E:6651 ||| IN
the  ||| S:6651 E:6666 ||| DT
S.  ||| S:6666 E:6669 ||| NNP
pombe  ||| S:6669 E:6675 ||| VBD
CSN ||| S:6675 E:6678 ||| NNP
,  ||| S:6678 E:6680 ||| ,
which  ||| S:6680 E:6686 ||| WDT
co-fractionate  ||| S:6686 E:6711 ||| JJ
with  ||| S:6711 E:6716 ||| IN
Csn1p  ||| S:6716 E:6722 ||| CD
upon  ||| S:6722 E:6727 ||| IN
size  ||| S:6727 E:6732 ||| NN
exclusion  ||| S:6732 E:6742 ||| NN
chromatography  ||| S:6742 E:6757 ||| NNS
( ||| S:6757 E:6758 ||| -LRB-
see  ||| S:6758 E:6762 ||| VB
below ||| S:6762 E:6767 ||| RB
,  ||| S:6767 E:6779 ||| ,
Fig.  ||| S:6779 E:6784 ||| CD
4 ||| S:6784 E:6785 ||| CD
) ||| S:6785 E:6786 ||| -RRB-
.  ||| S:6786 E:6788 ||| .
However ||| S:6788 E:6795 ||| RB
,  ||| S:6795 E:6797 ||| ,
unlike  ||| S:6797 E:6815 ||| IN
csn1  ||| S:6815 E:6820 ||| CD
disruptants ||| S:6820 E:6831 ||| NN
,  ||| S:6831 E:6833 ||| ,
which  ||| S:6833 E:6839 ||| WDT
have  ||| S:6839 E:6844 ||| VBP
a  ||| S:6844 E:6856 ||| DT
defect  ||| S:6856 E:6863 ||| NN
in  ||| S:6863 E:6866 ||| IN
S  ||| S:6866 E:6868 ||| NNP
phase  ||| S:6868 E:6874 ||| NN
control  ||| S:6874 E:6882 ||| NN
resulting  ||| S:6882 E:6892 ||| VBG
in  ||| S:6892 E:6895 ||| IN
slow  ||| S:6895 E:6900 ||| JJ
growth  ||| S:6900 E:6907 ||| NN
and  ||| S:6907 E:6921 ||| CC
cell  ||| S:6921 E:6926 ||| NN
elongation  ||| S:6926 E:6937 ||| NNS
[  ||| S:6937 E:6939 ||| -LRB-
21 ||| S:6939 E:6941 ||| CD
] ||| S:6941 E:6942 ||| -RRB-
,  ||| S:6942 E:6944 ||| ,
deletion  ||| S:6944 E:6953 ||| NN
of  ||| S:6953 E:6967 ||| IN
csn3  ||| S:6967 E:6972 ||| NNP
,  ||| S:6972 E:6985 ||| ,
csn4  ||| S:6985 E:6990 ||| NNP
,  ||| S:6990 E:6992 ||| ,
and  ||| S:6992 E:7007 ||| CC
csn5  ||| S:7007 E:7012 ||| CD
genes  ||| S:7012 E:7018 ||| NNS
did  ||| S:7018 E:7022 ||| VBD
not  ||| S:7022 E:7026 ||| RB
cause  ||| S:7026 E:7032 ||| VB
cell  ||| S:7032 E:7047 ||| NN
elongation ||| S:7047 E:7057 ||| NN
,  ||| S:7057 E:7059 ||| ,
S  ||| S:7059 E:7061 ||| NNP
phase  ||| S:7061 E:7067 ||| NN
delay ||| S:7067 E:7072 ||| NN
,  ||| S:7072 E:7074 ||| ,
or  ||| S:7074 E:7077 ||| CC
any  ||| S:7077 E:7081 ||| DT
other  ||| S:7081 E:7087 ||| JJ
obvious  ||| S:7087 E:7095 ||| JJ
growth  ||| S:7095 E:7112 ||| NN
defects  ||| S:7112 E:7120 ||| NNS
( ||| S:7120 E:7121 ||| -LRB-
Fig.  ||| S:7121 E:7126 ||| NNP
2C ||| S:7126 E:7128 ||| NNP
,  ||| S:7128 E:7130 ||| ,
2D ||| S:7130 E:7132 ||| NNP
,  ||| S:7132 E:7134 ||| ,
data  ||| S:7134 E:7139 ||| NNS
not  ||| S:7139 E:7143 ||| RB
shown ||| S:7143 E:7148 ||| VBN
) ||| S:7148 E:7149 ||| -RRB-
.  ||| S:7149 E:7151 ||| .
This  ||| S:7151 E:7156 ||| DT
indicates  ||| S:7156 E:7176 ||| VBZ
that  ||| S:7176 E:7181 ||| IN
the  ||| S:7181 E:7185 ||| DT
described  ||| S:7185 E:7195 ||| JJ
phenotype  ||| S:7195 E:7205 ||| NN
of  ||| S:7205 E:7219 ||| IN
csn1  ||| S:7219 E:7224 ||| CD
mutants  ||| S:7224 E:7232 ||| NNS
[  ||| S:7232 E:7234 ||| -LRB-
21 ||| S:7234 E:7236 ||| CD
]  ||| S:7236 E:7238 ||| -RRB-
is  ||| S:7238 E:7241 ||| VBZ
unlikely  ||| S:7241 E:7250 ||| JJ
to  ||| S:7250 E:7263 ||| TO
be  ||| S:7263 E:7266 ||| VB
a  ||| S:7266 E:7268 ||| DT
consequence  ||| S:7268 E:7280 ||| NN
of  ||| S:7280 E:7283 ||| IN
interference  ||| S:7283 E:7296 ||| NN
with  ||| S:7296 E:7301 ||| IN
Pcu3p  ||| S:7301 E:7307 ||| CD
activity ||| S:7307 E:7315 ||| NN
.  ||| S:7315 E:7327 ||| .
Pcu1p ||| S:7327 E:7332 ||| NNP
,  ||| S:7332 E:7334 ||| ,
another  ||| S:7334 E:7342 ||| DT
fission  ||| S:7342 E:7350 ||| JJ
yeast  ||| S:7350 E:7356 ||| NN
cullin  ||| S:7356 E:7363 ||| VBZ
also  ||| S:7363 E:7368 ||| RB
accumulated  ||| S:7368 E:7380 ||| VBN
in  ||| S:7380 E:7393 ||| IN
the  ||| S:7393 E:7397 ||| DT
neddylated  ||| S:7397 E:7408 ||| JJ
form  ||| S:7408 E:7413 ||| NN
in  ||| S:7413 E:7416 ||| IN
all  ||| S:7416 E:7431 ||| DT
csn  ||| S:7431 E:7435 ||| JJ
mutants  ||| S:7435 E:7443 ||| NNS
[  ||| S:7443 E:7445 ||| -LRB-
10 ||| S:7445 E:7447 ||| CD
]  ||| S:7447 E:7449 ||| -RRB-
( ||| S:7449 E:7450 ||| -LRB-
Fig.  ||| S:7450 E:7455 ||| NNP
2A ||| S:7455 E:7457 ||| NNP
) ||| S:7457 E:7458 ||| -RRB-
,  ||| S:7458 E:7470 ||| ,
suggesting  ||| S:7470 E:7481 ||| VBG
that  ||| S:7481 E:7486 ||| IN
CSN  ||| S:7486 E:7490 ||| NNP
has  ||| S:7490 E:7494 ||| VBZ
a  ||| S:7494 E:7496 ||| DT
general  ||| S:7496 E:7504 ||| JJ
role  ||| S:7504 E:7509 ||| NN
in  ||| S:7509 E:7512 ||| IN
the  ||| S:7512 E:7516 ||| DT
control  ||| S:7516 E:7524 ||| NN
of  ||| S:7524 E:7537 ||| IN
cullin  ||| S:7537 E:7544 ||| JJ
neddylation  ||| S:7544 E:7556 ||| NN
in  ||| S:7556 E:7559 ||| IN
fission  ||| S:7559 E:7567 ||| JJ
yeast ||| S:7567 E:7572 ||| NN
.  ||| S:7572 E:7574 ||| .
The  ||| S:7574 E:7578 ||| DT
accumulation  ||| S:7578 E:7591 ||| NN
of  ||| S:7591 E:7604 ||| IN
neddylated  ||| S:7604 E:7615 ||| JJ
Pcu3p  ||| S:7615 E:7621 ||| NN
was  ||| S:7621 E:7625 ||| VBD
prevented  ||| S:7625 E:7635 ||| VBN
in  ||| S:7635 E:7638 ||| IN
all  ||| S:7638 E:7653 ||| DT
csn  ||| S:7653 E:7657 ||| JJ
mutants  ||| S:7657 E:7665 ||| NN
by  ||| S:7665 E:7668 ||| IN
providing  ||| S:7668 E:7678 ||| VBG
the  ||| S:7678 E:7692 ||| DT
missing  ||| S:7692 E:7700 ||| JJ
CSN  ||| S:7700 E:7704 ||| NNP
subunit  ||| S:7704 E:7712 ||| NN
on  ||| S:7712 E:7715 ||| IN
a  ||| S:7715 E:7717 ||| DT
plasmid  ||| S:7717 E:7725 ||| NN
( ||| S:7725 E:7726 ||| -LRB-
Fig.  ||| S:7726 E:7731 ||| CD
3 ||| S:7731 E:7732 ||| CD
) ||| S:7732 E:7733 ||| -RRB-
.  ||| S:7733 E:7763 ||| .
The  ||| S:7763 E:7767 ||| DT
conserved  ||| S:7767 E:7777 ||| JJ
"cysteine  ||| S:7777 E:7787 ||| CD
box ||| S:7787 E:7790 ||| NN
"  ||| S:7790 E:7792 ||| ''
in  ||| S:7792 E:7795 ||| IN
Csn5p  ||| S:7795 E:7801 ||| NNP
is  ||| S:7801 E:7804 ||| VBZ
not  ||| S:7804 E:7818 ||| RB
required  ||| S:7818 E:7827 ||| VBN
for  ||| S:7827 E:7831 ||| IN
Pcu3p  ||| S:7831 E:7837 ||| FW
deneddylation  ||| S:7837 E:7861 ||| FW
Lyapina  ||| S:7861 E:7880 ||| FW
et  ||| S:7880 E:7883 ||| FW
al.  ||| S:7883 E:7887 ||| NNP
recently  ||| S:7887 E:7896 ||| RB
demonstrated  ||| S:7896 E:7909 ||| VBN
that  ||| S:7909 E:7924 ||| IN
partially  ||| S:7924 E:7934 ||| RB
purified  ||| S:7934 E:7943 ||| JJ
CSN  ||| S:7943 E:7947 ||| NNP
promotes  ||| S:7947 E:7956 ||| VBZ
the  ||| S:7956 E:7960 ||| DT
cleavage  ||| S:7960 E:7969 ||| NN
of  ||| S:7969 E:7982 ||| IN
Pcu1p-Ned8p  ||| S:7982 E:7994 ||| CD
conjugates  ||| S:7994 E:8016 ||| NN
in  ||| S:8016 E:8019 ||| IN
vitro  ||| S:8019 E:8025 ||| NNS
[  ||| S:8025 E:8027 ||| -LRB-
10 ||| S:8027 E:8029 ||| CD
] ||| S:8029 E:8030 ||| -RRB-
,  ||| S:8030 E:8032 ||| ,
but  ||| S:8032 E:8036 ||| CC
it  ||| S:8036 E:8039 ||| PRP
remained  ||| S:8039 E:8058 ||| VBD
unclear  ||| S:8058 E:8066 ||| JJ
whether  ||| S:8066 E:8074 ||| IN
the  ||| S:8074 E:8078 ||| DT
enzymatic  ||| S:8078 E:8088 ||| JJ
activity  ||| S:8088 E:8097 ||| NN
is  ||| S:8097 E:8100 ||| VBZ
contained  ||| S:8100 E:8120 ||| VBN
within  ||| S:8120 E:8127 ||| IN
one  ||| S:8127 E:8131 ||| CD
of  ||| S:8131 E:8134 ||| IN
the  ||| S:8134 E:8138 ||| DT
CSN  ||| S:8138 E:8142 ||| NNP
subunits  ||| S:8142 E:8151 ||| NN
or  ||| S:8151 E:8154 ||| CC
a  ||| S:8154 E:8156 ||| DT
tightly  ||| S:8156 E:8164 ||| RB
associated  ||| S:8164 E:8185 ||| VBN
peptidase ||| S:8185 E:8194 ||| NN
.  ||| S:8194 E:8196 ||| .
All  ||| S:8196 E:8200 ||| DT
peptidases  ||| S:8200 E:8211 ||| NN
known  ||| S:8211 E:8217 ||| VBN
to  ||| S:8217 E:8220 ||| TO
cleave  ||| S:8220 E:8227 ||| VB
ubiquitin-  ||| S:8227 E:8238 ||| JJ
or  ||| S:8238 E:8251 ||| CC
SUMO-protein  ||| S:8251 E:8264 ||| JJ
conjugates  ||| S:8264 E:8275 ||| NNS
are  ||| S:8275 E:8279 ||| VBP
cysteine-based  ||| S:8279 E:8294 ||| JJ
proteases  ||| S:8294 E:8314 ||| NNS
( ||| S:8314 E:8315 ||| -LRB-
reviewed  ||| S:8315 E:8324 ||| VBN
in  ||| S:8324 E:8327 ||| IN
ref.  ||| S:8327 E:8332 ||| NNP
[  ||| S:8332 E:8334 ||| -LRB-
22 ||| S:8334 E:8336 ||| CD
] ||| S:8336 E:8337 ||| CD
) ||| S:8337 E:8338 ||| -RRB-
.  ||| S:8338 E:8340 ||| .
Csn5p  ||| S:8340 E:8346 ||| NNP
contains  ||| S:8346 E:8355 ||| VBZ
a  ||| S:8355 E:8357 ||| DT
motif  ||| S:8357 E:8363 ||| NN
closely  ||| S:8363 E:8381 ||| RB
resembling  ||| S:8381 E:8392 ||| VBG
the  ||| S:8392 E:8396 ||| DT
conserved  ||| S:8396 E:8406 ||| JJ
cysteine  ||| S:8406 E:8415 ||| JJ
box  ||| S:8415 E:8419 ||| NN
previously  ||| S:8419 E:8440 ||| RB
recognized  ||| S:8440 E:8451 ||| VBN
in  ||| S:8451 E:8454 ||| IN
the  ||| S:8454 E:8458 ||| DT
catalytic  ||| S:8458 E:8468 ||| JJ
center  ||| S:8468 E:8475 ||| NN
of  ||| S:8475 E:8478 ||| IN
deubiquitylating  ||| S:8478 E:8505 ||| JJ
enzymes  ||| S:8505 E:8513 ||| NN
and  ||| S:8513 E:8517 ||| CC
in  ||| S:8517 E:8520 ||| IN
the  ||| S:8520 E:8524 ||| DT
budding  ||| S:8524 E:8532 ||| FW
yeast  ||| S:8532 E:8538 ||| FW
proteasome  ||| S:8538 E:8549 ||| FW
subunit  ||| S:8549 E:8567 ||| FW
Rpn11p  ||| S:8567 E:8574 ||| FW
[  ||| S:8574 E:8576 ||| -LRB-
23 ||| S:8576 E:8578 ||| CD
] ||| S:8578 E:8579 ||| -RRB-
.  ||| S:8579 E:8581 ||| .
The  ||| S:8581 E:8585 ||| DT
complementation  ||| S:8585 E:8601 ||| JJ
assay  ||| S:8601 E:8607 ||| NNS
shown  ||| S:8607 E:8613 ||| VBN
in  ||| S:8613 E:8616 ||| IN
Fig.  ||| S:8616 E:8631 ||| CD
3allowed  ||| S:8631 E:8640 ||| CD
us  ||| S:8640 E:8643 ||| PRP
to  ||| S:8643 E:8646 ||| TO
determine  ||| S:8646 E:8656 ||| VB
the  ||| S:8656 E:8660 ||| DT
potential  ||| S:8660 E:8670 ||| JJ
role  ||| S:8670 E:8675 ||| NN
of  ||| S:8675 E:8678 ||| IN
this  ||| S:8678 E:8683 ||| DT
motif  ||| S:8683 E:8699 ||| NN
in  ||| S:8699 E:8702 ||| IN
the  ||| S:8702 E:8706 ||| DT
control  ||| S:8706 E:8714 ||| NN
of  ||| S:8714 E:8717 ||| IN
Pcu3p  ||| S:8717 E:8723 ||| CD
neddylation  ||| S:8723 E:8735 ||| NN
by  ||| S:8735 E:8738 ||| IN
replacing  ||| S:8738 E:8748 ||| VBG
the  ||| S:8748 E:8762 ||| DT
critical  ||| S:8762 E:8771 ||| JJ
cysteine  ||| S:8771 E:8780 ||| JJ
residue  ||| S:8780 E:8788 ||| NN
with  ||| S:8788 E:8793 ||| IN
alanine ||| S:8793 E:8800 ||| NN
.  ||| S:8800 E:8802 ||| .
This  ||| S:8802 E:8807 ||| DT
mutant  ||| S:8807 E:8814 ||| JJ
Csn5p  ||| S:8814 E:8830 ||| NN
retained  ||| S:8830 E:8839 ||| VBD
full  ||| S:8839 E:8844 ||| JJ
activity  ||| S:8844 E:8853 ||| NN
for  ||| S:8853 E:8857 ||| IN
preventing  ||| S:8857 E:8868 ||| VBG
Pcu1p  ||| S:8868 E:8874 ||| NNP
and  ||| S:8874 E:8878 ||| CC
Pcu3p  ||| S:8878 E:8894 ||| CD
hyperneddylation  ||| S:8894 E:8911 ||| NNS
( ||| S:8911 E:8912 ||| -LRB-
Fig.  ||| S:8912 E:8917 ||| NNP
3Alanes  ||| S:8917 E:8925 ||| NNP
12-15 ||| S:8925 E:8930 ||| NNP
,  ||| S:8930 E:8932 ||| ,
and  ||| S:8932 E:8936 ||| CC
data  ||| S:8936 E:8941 ||| NNS
not  ||| S:8941 E:8955 ||| RB
shown ||| S:8955 E:8960 ||| VBN
) ||| S:8960 E:8961 ||| -RRB-
.  ||| S:8961 E:8991 ||| .
Pcu3p  ||| S:8991 E:8997 ||| NNP
interacts  ||| S:8997 E:9007 ||| NN
with  ||| S:9007 E:9012 ||| IN
CSN  ||| S:9012 E:9026 ||| NNP
We  ||| S:9026 E:9029 ||| PRP
next  ||| S:9029 E:9034 ||| RB
determined  ||| S:9034 E:9045 ||| VBN
whether  ||| S:9045 E:9053 ||| IN
the  ||| S:9053 E:9057 ||| DT
effect  ||| S:9057 E:9064 ||| NN
of  ||| S:9064 E:9067 ||| IN
CSN  ||| S:9067 E:9081 ||| NNP
deficiency  ||| S:9081 E:9092 ||| NN
on  ||| S:9092 E:9095 ||| IN
Pcu3p  ||| S:9095 E:9101 ||| CD
neddylation  ||| S:9101 E:9113 ||| NN
reflects  ||| S:9113 E:9122 ||| VBZ
a  ||| S:9122 E:9124 ||| DT
physical  ||| S:9124 E:9143 ||| JJ
interaction  ||| S:9143 E:9155 ||| NN
of  ||| S:9155 E:9158 ||| IN
these  ||| S:9158 E:9164 ||| DT
proteins ||| S:9164 E:9172 ||| NNS
.  ||| S:9172 E:9174 ||| .
Size  ||| S:9174 E:9179 ||| NN
exclusion  ||| S:9179 E:9199 ||| NN
chromatography  ||| S:9199 E:9214 ||| NN
of  ||| S:9214 E:9217 ||| IN
lysates  ||| S:9217 E:9225 ||| VBG
prepared  ||| S:9225 E:9234 ||| VBN
from  ||| S:9234 E:9239 ||| IN
cells  ||| S:9239 E:9245 ||| NNS
harboring  ||| S:9245 E:9265 ||| VBG
epitope-tagged  ||| S:9265 E:9280 ||| JJ
Pcu3p  ||| S:9280 E:9286 ||| NN
or  ||| S:9286 E:9289 ||| CC
CSN  ||| S:9289 E:9293 ||| NNP
subunits  ||| S:9293 E:9302 ||| NN
at  ||| S:9302 E:9305 ||| IN
the  ||| S:9305 E:9309 ||| DT
endogenous  ||| S:9309 E:9330 ||| JJ
genomic  ||| S:9330 E:9338 ||| JJ
loci ||| S:9338 E:9342 ||| NN
,  ||| S:9342 E:9344 ||| ,
revealed  ||| S:9344 E:9353 ||| VBD
precise  ||| S:9353 E:9361 ||| JJ
co-elution  ||| S:9361 E:9372 ||| NN
of  ||| S:9372 E:9375 ||| IN
Pcu3p  ||| S:9375 E:9381 ||| CD
with  ||| S:9381 E:9396 ||| IN
CSN  ||| S:9396 E:9400 ||| NNP
subunits  ||| S:9400 E:9409 ||| VBD
1 ||| S:9409 E:9410 ||| CD
,  ||| S:9410 E:9412 ||| ,
3 ||| S:9412 E:9413 ||| CD
,  ||| S:9413 E:9415 ||| ,
4 ||| S:9415 E:9416 ||| CD
,  ||| S:9416 E:9418 ||| ,
and  ||| S:9418 E:9422 ||| CC
5  ||| S:9422 E:9424 ||| CD
in  ||| S:9424 E:9427 ||| IN
high  ||| S:9427 E:9432 ||| JJ
molecular  ||| S:9432 E:9442 ||| JJ
weight  ||| S:9442 E:9459 ||| NN
fractions  ||| S:9459 E:9469 ||| NNS
corresponding  ||| S:9469 E:9483 ||| JJ
to  ||| S:9483 E:9486 ||| TO
approximately  ||| S:9486 E:9500 ||| RB
550  ||| S:9500 E:9504 ||| CD
kDa  ||| S:9504 E:9508 ||| NNS
( ||| S:9508 E:9509 ||| -LRB-
Fig.  ||| S:9509 E:9524 ||| NNP
4A ||| S:9524 E:9526 ||| NNP
) ||| S:9526 E:9527 ||| -RRB-
.  ||| S:9527 E:9529 ||| .
Interestingly ||| S:9529 E:9542 ||| RB
,  ||| S:9542 E:9544 ||| ,
Csn5p ||| S:9544 E:9549 ||| NNP
,  ||| S:9549 E:9551 ||| ,
unlike  ||| S:9551 E:9558 ||| IN
the  ||| S:9558 E:9562 ||| DT
other  ||| S:9562 E:9568 ||| JJ
CSN  ||| S:9568 E:9572 ||| NNP
subunits ||| S:9572 E:9580 ||| NN
,  ||| S:9580 E:9592 ||| ,
showed  ||| S:9592 E:9599 ||| VBD
a  ||| S:9599 E:9601 ||| DT
second  ||| S:9601 E:9608 ||| JJ
peak  ||| S:9608 E:9613 ||| NN
in  ||| S:9613 E:9616 ||| IN
gel  ||| S:9616 E:9620 ||| JJ
filtration  ||| S:9620 E:9631 ||| JJ
eluting  ||| S:9631 E:9639 ||| NN
with  ||| S:9639 E:9644 ||| IN
an  ||| S:9644 E:9657 ||| DT
approximate  ||| S:9657 E:9669 ||| JJ
molecular  ||| S:9669 E:9679 ||| JJ
weight  ||| S:9679 E:9686 ||| NN
of  ||| S:9686 E:9689 ||| IN
200  ||| S:9689 E:9693 ||| CD
kDa ||| S:9693 E:9696 ||| NN
,  ||| S:9696 E:9698 ||| ,
suggesting  ||| S:9698 E:9709 ||| VBG
that  ||| S:9709 E:9724 ||| IN
Csn5p  ||| S:9724 E:9730 ||| NNP
may  ||| S:9730 E:9734 ||| MD
also  ||| S:9734 E:9739 ||| RB
be  ||| S:9739 E:9742 ||| VB
involved  ||| S:9742 E:9751 ||| VBN
in  ||| S:9751 E:9754 ||| IN
protein  ||| S:9754 E:9762 ||| NN
complexes  ||| S:9762 E:9772 ||| NNS
separate  ||| S:9772 E:9791 ||| JJ
from  ||| S:9791 E:9796 ||| IN
the  ||| S:9796 E:9800 ||| DT
entire  ||| S:9800 E:9807 ||| JJ
CSN  ||| S:9807 E:9811 ||| NNP
( ||| S:9811 E:9812 ||| -LRB-
Fig.  ||| S:9812 E:9817 ||| NNP
4B ||| S:9817 E:9819 ||| NNP
) ||| S:9819 E:9820 ||| -RRB-
.  ||| S:9820 E:9832 ||| .
Based  ||| S:9832 E:9838 ||| VBN
on  ||| S:9838 E:9841 ||| IN
the  ||| S:9841 E:9845 ||| DT
co-elution  ||| S:9845 E:9856 ||| JJ
of  ||| S:9856 E:9859 ||| IN
Pcu3p  ||| S:9859 E:9865 ||| CD
with  ||| S:9865 E:9870 ||| IN
CSN  ||| S:9870 E:9874 ||| NNP
subunits  ||| S:9874 E:9883 ||| NN
in  ||| S:9883 E:9896 ||| IN
gel  ||| S:9896 E:9900 ||| JJ
filtration ||| S:9900 E:9910 ||| NN
,  ||| S:9910 E:9912 ||| ,
we  ||| S:9912 E:9915 ||| PRP
determined  ||| S:9915 E:9926 ||| VBD
whether  ||| S:9926 E:9934 ||| IN
Pcu3p  ||| S:9934 E:9940 ||| NNP
and  ||| S:9940 E:9944 ||| CC
Csn1p  ||| S:9944 E:9960 ||| CD
interact  ||| S:9960 E:9980 ||| NN
in  ||| S:9980 E:9983 ||| IN
vivo  ||| S:9983 E:9988 ||| NN
at  ||| S:9988 E:9991 ||| IN
endogenous  ||| S:9991 E:10002 ||| JJ
expression  ||| S:10002 E:10023 ||| NN
levels ||| S:10023 E:10029 ||| NNS
.  ||| S:10029 E:10031 ||| .
Pcu3-Myc  ||| S:10031 E:10040 ||| NNP
immunoprecipitated  ||| S:10040 E:10059 ||| NN
from  ||| S:10059 E:10064 ||| IN
lysates  ||| S:10064 E:10072 ||| NN
of  ||| S:10072 E:10075 ||| IN
cells  ||| S:10075 E:10091 ||| NNS
expressing  ||| S:10091 E:10102 ||| VBG
HA-tagged  ||| S:10102 E:10112 ||| JJ
Csn1p  ||| S:10112 E:10118 ||| NN
together  ||| S:10118 E:10127 ||| RB
with  ||| S:10127 E:10132 ||| IN
Pcu3p-Myc  ||| S:10132 E:10142 ||| CD
from  ||| S:10142 E:10157 ||| IN
the  ||| S:10157 E:10161 ||| DT
endogenous  ||| S:10161 E:10172 ||| JJ
promoters  ||| S:10172 E:10182 ||| NNS
revealed  ||| S:10182 E:10191 ||| VBD
co-precipitation  ||| S:10191 E:10208 ||| JJ
of  ||| S:10208 E:10221 ||| IN
Csn1p-HA ||| S:10221 E:10229 ||| CD
.  ||| S:10229 E:10231 ||| .
This  ||| S:10231 E:10236 ||| DT
interaction  ||| S:10236 E:10248 ||| NN
was  ||| S:10248 E:10252 ||| VBD
specific  ||| S:10252 E:10261 ||| JJ
as  ||| S:10261 E:10264 ||| IN
it  ||| S:10264 E:10267 ||| PRP
was  ||| S:10267 E:10271 ||| VBD
not  ||| S:10271 E:10285 ||| RB
observed  ||| S:10285 E:10294 ||| VBN
with  ||| S:10294 E:10299 ||| IN
an  ||| S:10299 E:10302 ||| DT
irrelevant  ||| S:10302 E:10313 ||| JJ
antibody  ||| S:10313 E:10322 ||| NN
( ||| S:10322 E:10323 ||| -LRB-
Fig.  ||| S:10323 E:10328 ||| CD
4Cleft  ||| S:10328 E:10335 ||| CD
panel ||| S:10335 E:10340 ||| NN
)  ||| S:10340 E:10352 ||| -RRB-
or  ||| S:10352 E:10355 ||| CC
with  ||| S:10355 E:10360 ||| IN
lysate  ||| S:10360 E:10367 ||| NN
from  ||| S:10367 E:10372 ||| IN
a  ||| S:10372 E:10374 ||| DT
strain  ||| S:10374 E:10381 ||| FW
containing  ||| S:10381 E:10392 ||| FW
untagged  ||| S:10392 E:10401 ||| FW
Pcu3p  ||| S:10401 E:10417 ||| FW
( ||| S:10417 E:10418 ||| -LRB-
Fig.  ||| S:10418 E:10423 ||| NNP
4C ||| S:10423 E:10425 ||| NNP
,  ||| S:10425 E:10427 ||| ,
right  ||| S:10427 E:10433 ||| JJ
panel ||| S:10433 E:10438 ||| NN
) ||| S:10438 E:10439 ||| -RRB-
.  ||| S:10439 E:10441 ||| .
In  ||| S:10441 E:10444 ||| IN
contrast ||| S:10444 E:10452 ||| NN
,  ||| S:10452 E:10454 ||| ,
immunoprecipitation  ||| S:10454 E:10484 ||| VBG
with  ||| S:10484 E:10489 ||| IN
HA  ||| S:10489 E:10492 ||| NNP
antibodies  ||| S:10492 E:10503 ||| NNS
failed  ||| S:10503 E:10510 ||| VBD
to  ||| S:10510 E:10513 ||| TO
precipitate  ||| S:10513 E:10525 ||| VB
both  ||| S:10525 E:10530 ||| DT
Csn1p-3HA  ||| S:10530 E:10550 ||| NNP
and  ||| S:10550 E:10554 ||| CC
Pcu3p-Myc ||| S:10554 E:10563 ||| NNP
,  ||| S:10563 E:10565 ||| ,
potentially  ||| S:10565 E:10577 ||| RB
due  ||| S:10577 E:10581 ||| JJ
to  ||| S:10581 E:10584 ||| TO
inaccessibility  ||| S:10584 E:10600 ||| VB
of  ||| S:10600 E:10603 ||| IN
the  ||| S:10603 E:10617 ||| DT
C-terminal  ||| S:10617 E:10628 ||| JJ
3HA  ||| S:10628 E:10632 ||| CD
tag  ||| S:10632 E:10636 ||| NN
of  ||| S:10636 E:10639 ||| IN
Csn1p  ||| S:10639 E:10645 ||| CD
within  ||| S:10645 E:10652 ||| IN
the  ||| S:10652 E:10656 ||| DT
CSN  ||| S:10656 E:10660 ||| NNP
complex  ||| S:10660 E:10668 ||| NN
( ||| S:10668 E:10669 ||| -LRB-
data  ||| S:10669 E:10684 ||| NNS
not  ||| S:10684 E:10688 ||| RB
shown ||| S:10688 E:10693 ||| VBN
) ||| S:10693 E:10694 ||| -RRB-
.  ||| S:10694 E:10706 ||| .
We  ||| S:10706 E:10709 ||| PRP
therefore  ||| S:10709 E:10719 ||| RB
generated  ||| S:10719 E:10729 ||| FW
Pcu3p-Myc  ||| S:10729 E:10739 ||| FW
containing  ||| S:10739 E:10750 ||| FW
strains  ||| S:10750 E:10768 ||| FW
overexpressing  ||| S:10768 E:10783 ||| FW
N-terminally  ||| S:10783 E:10796 ||| FW
6xhistidine-Myc-tagged  ||| S:10796 E:10819 ||| FW
Csn1p ||| S:10819 E:10824 ||| FW
,  ||| S:10824 E:10836 ||| ,
Csn3p ||| S:10836 E:10841 ||| NNP
,  ||| S:10841 E:10843 ||| ,
Csn4p ||| S:10843 E:10848 ||| NNP
,  ||| S:10848 E:10850 ||| ,
or  ||| S:10850 E:10853 ||| CC
Csn5p ||| S:10853 E:10858 ||| NNP
.  ||| S:10858 E:10860 ||| .
Binding  ||| S:10860 E:10868 ||| VBG
of  ||| S:10868 E:10871 ||| IN
each  ||| S:10871 E:10876 ||| DT
of  ||| S:10876 E:10879 ||| IN
the  ||| S:10879 E:10883 ||| DT
four  ||| S:10883 E:10898 ||| CD
different  ||| S:10898 E:10908 ||| JJ
CSN  ||| S:10908 E:10912 ||| NNP
subunits  ||| S:10912 E:10921 ||| VBD
to  ||| S:10921 E:10924 ||| TO
nickel  ||| S:10924 E:10931 ||| VB
beads  ||| S:10931 E:10937 ||| VBN
resulted  ||| S:10937 E:10946 ||| VBN
in  ||| S:10946 E:10959 ||| IN
co-purification  ||| S:10959 E:10975 ||| JJ
of  ||| S:10975 E:10978 ||| IN
Pcu3p ||| S:10978 E:10983 ||| NNP
,  ||| S:10983 E:10985 ||| ,
indicative  ||| S:10985 E:10996 ||| JJ
of  ||| S:10996 E:10999 ||| IN
specific  ||| S:10999 E:11019 ||| JJ
in  ||| S:11019 E:11022 ||| IN
vivo  ||| S:11022 E:11027 ||| JJ
interactions  ||| S:11027 E:11040 ||| NNS
( ||| S:11040 E:11041 ||| -LRB-
Fig.  ||| S:11041 E:11046 ||| NNP
4C ||| S:11046 E:11048 ||| NNP
) ||| S:11048 E:11049 ||| -RRB-
.  ||| S:11049 E:11061 ||| .
Notably ||| S:11061 E:11068 ||| RB
,  ||| S:11068 E:11070 ||| ,
both  ||| S:11070 E:11075 ||| DT
modified  ||| S:11075 E:11084 ||| NN
and  ||| S:11084 E:11088 ||| CC
unmodified  ||| S:11088 E:11099 ||| CD
Pcu3p  ||| S:11099 E:11105 ||| CD
interacted  ||| S:11105 E:11126 ||| NN
with  ||| S:11126 E:11131 ||| IN
CSN  ||| S:11131 E:11135 ||| NNP
subunits  ||| S:11135 E:11144 ||| NNS
( ||| S:11144 E:11145 ||| -LRB-
Fig.  ||| S:11145 E:11150 ||| NNP
4C ||| S:11150 E:11152 ||| NNP
) ||| S:11152 E:11153 ||| -RRB-
.  ||| S:11153 E:11155 ||| .
We  ||| S:11155 E:11158 ||| PRP
conclude  ||| S:11158 E:11167 ||| VBP
that ||| S:11167 E:11171 ||| RB
,  ||| S:11171 E:11173 ||| ,
at  ||| S:11173 E:11176 ||| IN
least  ||| S:11176 E:11182 ||| JJS
a  ||| S:11182 E:11194 ||| DT
fraction  ||| S:11194 E:11203 ||| NN
of  ||| S:11203 E:11206 ||| IN
Pcu3p  ||| S:11206 E:11212 ||| CD
forms  ||| S:11212 E:11218 ||| NNS
a  ||| S:11218 E:11220 ||| DT
stable  ||| S:11220 E:11227 ||| JJ
complex  ||| S:11227 E:11235 ||| NN
with  ||| S:11235 E:11240 ||| IN
CSN  ||| S:11240 E:11255 ||| NNP
in  ||| S:11255 E:11258 ||| IN
vivo  ||| S:11258 E:11263 ||| NN
.  ||| S:11263 E:11293 ||| .
Pcu3p  ||| S:11293 E:11299 ||| NNP
localization  ||| S:11299 E:11312 ||| NN
in  ||| S:11312 E:11315 ||| IN
csnmutants  ||| S:11315 E:11336 ||| NN
In  ||| S:11336 E:11350 ||| IN
A.  ||| S:11350 E:11353 ||| NNP
thaliana  ||| S:11353 E:11362 ||| NN
,  ||| S:11362 E:11364 ||| ,
CSN  ||| S:11364 E:11368 ||| NNP
was  ||| S:11368 E:11372 ||| VBD
shown  ||| S:11372 E:11378 ||| VBN
to  ||| S:11378 E:11381 ||| TO
be  ||| S:11381 E:11394 ||| VB
required  ||| S:11394 E:11403 ||| VBN
for  ||| S:11403 E:11407 ||| IN
the  ||| S:11407 E:11411 ||| DT
efficient  ||| S:11411 E:11421 ||| JJ
nuclear  ||| S:11421 E:11429 ||| JJ
accumulation  ||| S:11429 E:11442 ||| NN
of  ||| S:11442 E:11445 ||| IN
the  ||| S:11445 E:11459 ||| DT
putative  ||| S:11459 E:11468 ||| FW
RING-type  ||| S:11468 E:11478 ||| FW
ubiquitin  ||| S:11478 E:11488 ||| FW
ligase  ||| S:11488 E:11495 ||| FW
COP1  ||| S:11495 E:11500 ||| FW
[  ||| S:11500 E:11502 ||| -LRB-
24 ||| S:11502 E:11504 ||| CD
] ||| S:11504 E:11505 ||| -RRB-
,  ||| S:11505 E:11507 ||| ,
which  ||| S:11507 E:11523 ||| WDT
mediates  ||| S:11523 E:11532 ||| VBZ
ubiquitin-dependent  ||| S:11532 E:11552 ||| JJ
degradation  ||| S:11552 E:11564 ||| NN
of  ||| S:11564 E:11567 ||| IN
the  ||| S:11567 E:11581 ||| DT
photomorphogenic  ||| S:11581 E:11598 ||| FW
transcription  ||| S:11598 E:11612 ||| FW
factor  ||| S:11612 E:11619 ||| FW
HY5  ||| S:11619 E:11623 ||| FW
[  ||| S:11623 E:11625 ||| -LRB-
25 ||| S:11625 E:11627 ||| CD
] ||| S:11627 E:11628 ||| -RRB-
.  ||| S:11628 E:11630 ||| .
We  ||| S:11630 E:11643 ||| PRP
therefore  ||| S:11643 E:11653 ||| RB
considered  ||| S:11653 E:11664 ||| VBN
the  ||| S:11664 E:11668 ||| DT
possibility  ||| S:11668 E:11680 ||| NN
that  ||| S:11680 E:11685 ||| IN
accumulation  ||| S:11685 E:11698 ||| NN
of  ||| S:11698 E:11711 ||| IN
neddylated  ||| S:11711 E:11722 ||| JJ
Pcu3p  ||| S:11722 E:11728 ||| NN
in  ||| S:11728 E:11742 ||| IN
csn  ||| S:11742 E:11746 ||| JJ
mutants  ||| S:11746 E:11754 ||| NN
is  ||| S:11754 E:11757 ||| VBZ
a  ||| S:11757 E:11759 ||| DT
consequence  ||| S:11759 E:11771 ||| NN
of  ||| S:11771 E:11784 ||| IN
defective  ||| S:11784 E:11794 ||| JJ
subcellular  ||| S:11794 E:11806 ||| NNS
targeting ||| S:11806 E:11815 ||| VBG
.  ||| S:11815 E:11817 ||| .
Indirect  ||| S:11817 E:11836 ||| JJ
immunofluorescence  ||| S:11836 E:11855 ||| NNS
staining  ||| S:11855 E:11864 ||| VBP
indicated  ||| S:11864 E:11874 ||| VBN
that  ||| S:11874 E:11879 ||| IN
endogenous  ||| S:11879 E:11900 ||| JJ
Myc-tagged  ||| S:11900 E:11911 ||| JJ
Pcu3p  ||| S:11911 E:11917 ||| NN
is  ||| S:11917 E:11920 ||| VBZ
present  ||| S:11920 E:11928 ||| JJ
in  ||| S:11928 E:11931 ||| IN
the  ||| S:11931 E:11935 ||| DT
cytoplasm ||| S:11935 E:11944 ||| NN
,  ||| S:11944 E:11946 ||| ,
but  ||| S:11946 E:11960 ||| CC
enriched  ||| S:11960 E:11969 ||| NN
in  ||| S:11969 E:11972 ||| IN
the  ||| S:11972 E:11976 ||| DT
nucleus  ||| S:11976 E:11984 ||| NN
of  ||| S:11984 E:11987 ||| IN
wild-type  ||| S:11987 E:11997 ||| JJ
cells  ||| S:11997 E:12003 ||| NNS
( ||| S:12003 E:12004 ||| -LRB-
Fig.  ||| S:12004 E:12009 ||| CD
5 ||| S:12009 E:12010 ||| CD
) ||| S:12010 E:12011 ||| -RRB-
.  ||| S:12011 E:12013 ||| .
This  ||| S:12013 E:12028 ||| DT
localization  ||| S:12028 E:12041 ||| JJ
pattern  ||| S:12041 E:12049 ||| NN
was  ||| S:12049 E:12053 ||| VBD
fully  ||| S:12053 E:12059 ||| RB
preserved  ||| S:12059 E:12069 ||| VBN
in  ||| S:12069 E:12072 ||| IN
all  ||| S:12072 E:12076 ||| DT
four  ||| S:12076 E:12092 ||| CD
csn  ||| S:12092 E:12096 ||| JJ
mutants ||| S:12096 E:12103 ||| NN
,  ||| S:12103 E:12105 ||| ,
indicating  ||| S:12105 E:12116 ||| VBG
that  ||| S:12116 E:12121 ||| IN
CSN  ||| S:12121 E:12135 ||| NNP
does  ||| S:12135 E:12140 ||| VBZ
not  ||| S:12140 E:12144 ||| RB
regulate  ||| S:12144 E:12153 ||| VB
the  ||| S:12153 E:12157 ||| DT
subcellular  ||| S:12157 E:12169 ||| JJ
localization  ||| S:12169 E:12182 ||| NN
of  ||| S:12182 E:12195 ||| IN
Pcu3p ||| S:12195 E:12200 ||| CD
.  ||| S:12200 E:12230 ||| .
Mutation  ||| S:12230 E:12239 ||| NN
of  ||| S:12239 E:12242 ||| IN
CSN  ||| S:12242 E:12246 ||| NNP
increases  ||| S:12246 E:12256 ||| VBZ
Pcu3p-dependent  ||| S:12256 E:12282 ||| RB
polyubiquitylation  ||| S:12282 E:12301 ||| JJ
activity  ||| S:12301 E:12320 ||| NN
All  ||| S:12320 E:12324 ||| DT
human  ||| S:12324 E:12330 ||| JJ
cullins  ||| S:12330 E:12338 ||| NNS
have  ||| S:12338 E:12343 ||| VBP
been  ||| S:12343 E:12348 ||| VBN
shown  ||| S:12348 E:12354 ||| VBN
to  ||| S:12354 E:12357 ||| TO
assemble  ||| S:12357 E:12366 ||| VB
into  ||| S:12366 E:12381 ||| IN
complexes  ||| S:12381 E:12391 ||| NNS
possessing  ||| S:12391 E:12402 ||| VBG
polyubiquitylation  ||| S:12402 E:12421 ||| JJ
activity  ||| S:12421 E:12441 ||| NN
in  ||| S:12441 E:12444 ||| IN
vitro  ||| S:12444 E:12450 ||| NNS
[  ||| S:12450 E:12452 ||| -LRB-
9 ||| S:12452 E:12453 ||| CD
,  ||| S:12453 E:12455 ||| ,
26 ||| S:12455 E:12457 ||| CD
] ||| S:12457 E:12458 ||| -RRB-
.  ||| S:12458 E:12460 ||| .
To  ||| S:12460 E:12463 ||| TO
determine  ||| S:12463 E:12483 ||| VB
whether  ||| S:12483 E:12491 ||| IN
Pcu3p  ||| S:12491 E:12497 ||| NNP
is  ||| S:12497 E:12500 ||| VBZ
associated  ||| S:12500 E:12511 ||| VBN
with  ||| S:12511 E:12516 ||| IN
such  ||| S:12516 E:12521 ||| PDT
an  ||| S:12521 E:12524 ||| DT
activity  ||| S:12524 E:12533 ||| NN
and  ||| S:12533 E:12537 ||| CC
how  ||| S:12537 E:12551 ||| WRB
it  ||| S:12551 E:12554 ||| PRP
is  ||| S:12554 E:12557 ||| VBZ
affected  ||| S:12557 E:12566 ||| VBN
by  ||| S:12566 E:12569 ||| IN
CSN ||| S:12569 E:12572 ||| NNP
,  ||| S:12572 E:12574 ||| ,
we  ||| S:12574 E:12577 ||| PRP
developed  ||| S:12577 E:12587 ||| VBD
a  ||| S:12587 E:12599 ||| DT
substrate-independent  ||| S:12599 E:12632 ||| JJ
in  ||| S:12632 E:12635 ||| IN
vitro  ||| S:12635 E:12641 ||| JJ
polyubiquitylation  ||| S:12641 E:12660 ||| JJ
assay ||| S:12660 E:12665 ||| NN
,  ||| S:12665 E:12677 ||| ,
similar  ||| S:12677 E:12685 ||| JJ
to  ||| S:12685 E:12688 ||| TO
that  ||| S:12688 E:12693 ||| WDT
originally  ||| S:12693 E:12704 ||| RB
reported  ||| S:12704 E:12713 ||| VBN
by  ||| S:12713 E:12716 ||| IN
Lyapina  ||| S:12716 E:12724 ||| NNP
et  ||| S:12724 E:12727 ||| FW
al.  ||| S:12727 E:12731 ||| FW
[  ||| S:12731 E:12743 ||| -LRB-
27 ||| S:12743 E:12745 ||| CD
] ||| S:12745 E:12746 ||| -RRB-
.  ||| S:12746 E:12748 ||| .
As  ||| S:12748 E:12751 ||| IN
Pcu3p-associated  ||| S:12751 E:12768 ||| CD
ubiquitin  ||| S:12768 E:12778 ||| CD
ligase  ||| S:12778 E:12785 ||| JJ
activity  ||| S:12785 E:12794 ||| NN
was  ||| S:12794 E:12808 ||| VBD
not  ||| S:12808 E:12812 ||| RB
described  ||| S:12812 E:12822 ||| VBN
before ||| S:12822 E:12828 ||| RB
,  ||| S:12828 E:12830 ||| ,
we  ||| S:12830 E:12833 ||| PRP
first  ||| S:12833 E:12839 ||| RB
needed  ||| S:12839 E:12846 ||| VBN
to  ||| S:12846 E:12849 ||| TO
determine  ||| S:12849 E:12859 ||| VB
which  ||| S:12859 E:12875 ||| WDT
of  ||| S:12875 E:12878 ||| IN
the  ||| S:12878 E:12882 ||| DT
fourteen  ||| S:12882 E:12891 ||| JJ
different  ||| S:12891 E:12901 ||| JJ
ubiquitin-conjugating  ||| S:12901 E:12923 ||| JJ
enzymes  ||| S:12923 E:12941 ||| NNS
( ||| S:12941 E:12942 ||| -LRB-
UBCs ||| S:12942 E:12946 ||| NNP
)  ||| S:12946 E:12948 ||| -RRB-
present  ||| S:12948 E:12956 ||| JJ
in  ||| S:12956 E:12959 ||| IN
the  ||| S:12959 E:12963 ||| DT
fission  ||| S:12963 E:12971 ||| JJ
yeast  ||| S:12971 E:12977 ||| NN
genome  ||| S:12977 E:12984 ||| NN
associate  ||| S:12984 E:12994 ||| NN
with  ||| S:12994 E:13009 ||| IN
the  ||| S:13009 E:13013 ||| DT
RING  ||| S:13013 E:13018 ||| NNP
domain  ||| S:13018 E:13025 ||| NN
protein  ||| S:13025 E:13033 ||| NN
Pip1p ||| S:13033 E:13038 ||| NN
,  ||| S:13038 E:13040 ||| ,
an  ||| S:13040 E:13043 ||| DT
essential  ||| S:13043 E:13053 ||| JJ
cofactor  ||| S:13053 E:13062 ||| NN
of  ||| S:13062 E:13075 ||| IN
cullin  ||| S:13075 E:13082 ||| FW
ubiquitin  ||| S:13082 E:13092 ||| FW
ligases  ||| S:13092 E:13100 ||| FW
[  ||| S:13100 E:13102 ||| -LRB-
7 ||| S:13102 E:13103 ||| CD
,  ||| S:13103 E:13105 ||| ,
28 ||| S:13105 E:13107 ||| CD
,  ||| S:13107 E:13109 ||| ,
29 ||| S:13109 E:13111 ||| CD
,  ||| S:13111 E:13113 ||| ,
30 ||| S:13113 E:13115 ||| CD
] ||| S:13115 E:13116 ||| -RRB-
.  ||| S:13116 E:13118 ||| .
Binding  ||| S:13118 E:13126 ||| JJ
assays  ||| S:13126 E:13143 ||| NN
showed  ||| S:13143 E:13150 ||| VBD
that  ||| S:13150 E:13155 ||| DT
overexpressed  ||| S:13155 E:13169 ||| JJ
HA-tagged  ||| S:13169 E:13179 ||| JJ
Pip1p  ||| S:13179 E:13185 ||| NN
specifically  ||| S:13185 E:13208 ||| RB
associated  ||| S:13208 E:13219 ||| VBN
with  ||| S:13219 E:13224 ||| IN
co-overexpressed  ||| S:13224 E:13241 ||| NNP
6xHis-Myc-tagged  ||| S:13241 E:13258 ||| NNP
Ubc1p ||| S:13258 E:13263 ||| NNP
,  ||| S:13263 E:13275 ||| ,
Ubc7p ||| S:13275 E:13280 ||| NNP
,  ||| S:13280 E:13282 ||| ,
Ubc11p ||| S:13282 E:13288 ||| NNP
,  ||| S:13288 E:13290 ||| ,
Ubc12p ||| S:13290 E:13296 ||| NNP
,  ||| S:13296 E:13298 ||| ,
Ubc13p ||| S:13298 E:13304 ||| NNP
,  ||| S:13304 E:13306 ||| ,
Ubc14p ||| S:13306 E:13312 ||| NNP
,  ||| S:13312 E:13314 ||| ,
and  ||| S:13314 E:13318 ||| CC
Mms2p ||| S:13318 E:13323 ||| NNP
.  ||| S:13323 E:13325 ||| .
In  ||| S:13325 E:13328 ||| IN
the  ||| S:13328 E:13342 ||| DT
next  ||| S:13342 E:13347 ||| JJ
step ||| S:13347 E:13351 ||| NN
,  ||| S:13351 E:13353 ||| ,
we  ||| S:13353 E:13356 ||| PRP
confirmed ||| S:13356 E:13365 ||| VBD
,  ||| S:13365 E:13367 ||| ,
by  ||| S:13367 E:13370 ||| IN
immunoprecipitation ||| S:13370 E:13389 ||| NN
,  ||| S:13389 E:13391 ||| ,
that  ||| S:13391 E:13406 ||| IN
both  ||| S:13406 E:13411 ||| DT
forms  ||| S:13411 E:13417 ||| NNS
of  ||| S:13417 E:13420 ||| IN
Pcu3p-Myc  ||| S:13420 E:13430 ||| CD
bound  ||| S:13430 E:13436 ||| CD
endogenous  ||| S:13436 E:13447 ||| CD
Pip1p  ||| S:13447 E:13453 ||| CD
in  ||| S:13453 E:13456 ||| IN
a  ||| S:13456 E:13468 ||| DT
CSN-independent  ||| S:13468 E:13484 ||| JJ
manner  ||| S:13484 E:13491 ||| NN
( ||| S:13491 E:13492 ||| -LRB-
Fig.  ||| S:13492 E:13497 ||| NNP
6B ||| S:13497 E:13499 ||| NNP
) ||| S:13499 E:13500 ||| -RRB-
.  ||| S:13500 E:13512 ||| .
Pcu3p-Myc  ||| S:13512 E:13522 ||| NNP
complexes  ||| S:13522 E:13532 ||| NNS
prepared  ||| S:13532 E:13541 ||| VBN
by  ||| S:13541 E:13544 ||| IN
immunoprecipitation  ||| S:13544 E:13574 ||| NN
with  ||| S:13574 E:13579 ||| IN
Myc  ||| S:13579 E:13583 ||| NNP
antibodies  ||| S:13583 E:13594 ||| NNS
were  ||| S:13594 E:13599 ||| VBD
then  ||| S:13599 E:13604 ||| RB
incubated  ||| S:13604 E:13614 ||| VBN
with  ||| S:13614 E:13619 ||| IN
human  ||| S:13619 E:13625 ||| JJ
E1 ||| S:13625 E:13627 ||| NN
,  ||| S:13627 E:13639 ||| ,
ATP ||| S:13639 E:13642 ||| NNP
,  ||| S:13642 E:13644 ||| ,
ubiquitin ||| S:13644 E:13653 ||| NN
,  ||| S:13653 E:13655 ||| ,
and  ||| S:13655 E:13659 ||| CC
the  ||| S:13659 E:13663 ||| DT
recombinant  ||| S:13663 E:13675 ||| JJ
UBCs  ||| S:13675 E:13680 ||| NN
that  ||| S:13680 E:13685 ||| IN
interacted  ||| S:13685 E:13706 ||| NN
with  ||| S:13706 E:13711 ||| IN
Pip1p ||| S:13711 E:13716 ||| CD
.  ||| S:13716 E:13718 ||| .
Polyubiquitylated  ||| S:13718 E:13736 ||| JJ
species  ||| S:13736 E:13744 ||| NNS
were  ||| S:13744 E:13749 ||| VBD
visualized  ||| S:13749 E:13760 ||| VBN
by  ||| S:13760 E:13773 ||| IN
anti-ubiquitin  ||| S:13773 E:13788 ||| JJ
blot ||| S:13788 E:13792 ||| NN
.  ||| S:13792 E:13794 ||| .
Pcu3p-Myc  ||| S:13794 E:13804 ||| NNP
complexes  ||| S:13804 E:13814 ||| NNS
isolated  ||| S:13814 E:13823 ||| VBN
from  ||| S:13823 E:13839 ||| IN
pcu3-13myc  ||| S:13839 E:13850 ||| CD
cells  ||| S:13850 E:13856 ||| NNS
did  ||| S:13856 E:13860 ||| VBD
not  ||| S:13860 E:13864 ||| RB
show  ||| S:13864 E:13869 ||| VB
any  ||| S:13869 E:13883 ||| DT
recognizable  ||| S:13883 E:13896 ||| JJ
polyubiquitylation  ||| S:13896 E:13915 ||| JJ
activity  ||| S:13915 E:13924 ||| NN
above  ||| S:13924 E:13930 ||| IN
background  ||| S:13930 E:13951 ||| NN
with  ||| S:13951 E:13956 ||| IN
any  ||| S:13956 E:13960 ||| DT
of  ||| S:13960 E:13963 ||| IN
the  ||| S:13963 E:13967 ||| DT
seven  ||| S:13967 E:13973 ||| CD
UBCs  ||| S:13973 E:13978 ||| JJ
tested  ||| S:13978 E:13985 ||| NNS
( ||| S:13985 E:13986 ||| -LRB-
Fig.  ||| S:13986 E:13991 ||| NNP
6C ||| S:13991 E:13993 ||| NNP
,  ||| S:13993 E:13995 ||| ,
lane  ||| S:13995 E:14000 ||| CD
2 ||| S:14000 E:14001 ||| CD
,  ||| S:14001 E:14003 ||| ,
and  ||| S:14003 E:14017 ||| CC
data  ||| S:14017 E:14022 ||| NNS
not  ||| S:14022 E:14026 ||| RB
shown ||| S:14026 E:14031 ||| VBN
) ||| S:14031 E:14032 ||| -RRB-
.  ||| S:14032 E:14034 ||| .
In  ||| S:14034 E:14037 ||| IN
contrast ||| S:14037 E:14045 ||| NN
,  ||| S:14045 E:14047 ||| ,
the  ||| S:14047 E:14051 ||| DT
ubiquitylation  ||| S:14051 E:14066 ||| JJ
assay  ||| S:14066 E:14082 ||| NN
with  ||| S:14082 E:14087 ||| IN
Pcu3p-Myc  ||| S:14087 E:14097 ||| CD
complexes  ||| S:14097 E:14107 ||| NNS
purified  ||| S:14107 E:14116 ||| VBN
from  ||| S:14116 E:14132 ||| IN
csn5  ||| S:14132 E:14137 ||| NNP
mutants  ||| S:14137 E:14145 ||| VBD
led  ||| S:14145 E:14149 ||| VBN
to  ||| S:14149 E:14152 ||| TO
efficient  ||| S:14152 E:14172 ||| JJ
formation  ||| S:14172 E:14182 ||| NN
of  ||| S:14182 E:14185 ||| IN
high  ||| S:14185 E:14190 ||| JJ
molecular  ||| S:14190 E:14200 ||| JJ
weight  ||| S:14200 E:14207 ||| NN
species  ||| S:14207 E:14215 ||| NNS
reactive  ||| S:14215 E:14224 ||| VBN
with  ||| S:14224 E:14239 ||| IN
ubiquitin  ||| S:14239 E:14249 ||| JJ
antibodies  ||| S:14249 E:14260 ||| NNS
( ||| S:14260 E:14261 ||| -LRB-
Fig.  ||| S:14261 E:14266 ||| NNP
6C ||| S:14266 E:14268 ||| NNP
) ||| S:14268 E:14269 ||| -RRB-
.  ||| S:14269 E:14271 ||| .
This  ||| S:14271 E:14276 ||| DT
activity  ||| S:14276 E:14285 ||| NN
was  ||| S:14285 E:14299 ||| VBD
specific  ||| S:14299 E:14308 ||| JJ
for  ||| S:14308 E:14312 ||| IN
Ubc7p  ||| S:14312 E:14318 ||| NNP
( ||| S:14318 E:14319 ||| -LRB-
Fig.  ||| S:14319 E:14324 ||| NNP
6C ||| S:14324 E:14326 ||| NNP
,  ||| S:14326 E:14328 ||| ,
compare  ||| S:14328 E:14336 ||| VBP
lanes  ||| S:14336 E:14342 ||| RB
3  ||| S:14342 E:14344 ||| CD
-  ||| S:14344 E:14346 ||| :
7 ||| S:14346 E:14347 ||| CD
) ||| S:14347 E:14348 ||| -RRB-
.  ||| S:14348 E:14360 ||| .
Appearance  ||| S:14360 E:14371 ||| NN
of  ||| S:14371 E:14374 ||| IN
multiubiquitin  ||| S:14374 E:14389 ||| JJ
chains  ||| S:14389 E:14396 ||| NNS
was  ||| S:14396 E:14400 ||| VBD
inhibited  ||| S:14400 E:14410 ||| VBN
by  ||| S:14410 E:14423 ||| IN
mutant  ||| S:14423 E:14430 ||| JJ
ubiquitin  ||| S:14430 E:14440 ||| NNS
lacking  ||| S:14440 E:14448 ||| VBG
all  ||| S:14448 E:14452 ||| DT
lysines ||| S:14452 E:14459 ||| NN
,  ||| S:14459 E:14461 ||| ,
indicating  ||| S:14461 E:14472 ||| VBG
that  ||| S:14472 E:14487 ||| IN
they  ||| S:14487 E:14492 ||| PRP
were  ||| S:14492 E:14497 ||| VBD
specifically  ||| S:14497 E:14510 ||| RB
generated  ||| S:14510 E:14520 ||| VBN
in  ||| S:14520 E:14523 ||| IN
the  ||| S:14523 E:14527 ||| DT
reaction  ||| S:14527 E:14536 ||| NN
rather  ||| S:14536 E:14553 ||| RB
than  ||| S:14553 E:14558 ||| IN
co-precipitated  ||| S:14558 E:14574 ||| JJ
with  ||| S:14574 E:14579 ||| IN
Pcu3p-Myc  ||| S:14579 E:14589 ||| NNP
( ||| S:14589 E:14590 ||| -LRB-
Fig.  ||| S:14590 E:14595 ||| NNP
6D ||| S:14595 E:14597 ||| NNP
) ||| S:14597 E:14598 ||| -RRB-
.  ||| S:14598 E:14600 ||| .
Thus ||| S:14600 E:14604 ||| RB
,  ||| S:14604 E:14606 ||| ,
CSN  ||| S:14606 E:14620 ||| NNP
deficiency  ||| S:14620 E:14631 ||| NN
appears  ||| S:14631 E:14639 ||| VBZ
to  ||| S:14639 E:14642 ||| TO
stimulate  ||| S:14642 E:14652 ||| VB
Pcu3p-associated  ||| S:14652 E:14679 ||| CD
ubiquitin  ||| S:14679 E:14689 ||| CD
ligase  ||| S:14689 E:14696 ||| JJ
activity  ||| S:14696 E:14716 ||| NN
in  ||| S:14716 E:14719 ||| IN
vitro  ||| S:14719 E:14725 ||| NN
.  ||| S:14725 E:14727 ||| .
A  ||| S:14727 E:14729 ||| DT
similar  ||| S:14729 E:14737 ||| JJ
stimulation  ||| S:14737 E:14759 ||| NN
was  ||| S:14759 E:14763 ||| VBD
obtained  ||| S:14763 E:14772 ||| VBN
for  ||| S:14772 E:14776 ||| IN
substrate-specific  ||| S:14776 E:14795 ||| JJ
polyubiquitylation  ||| S:14795 E:14814 ||| NN
of  ||| S:14814 E:14827 ||| IN
phosphorylated  ||| S:14827 E:14842 ||| JJ
Rum1p  ||| S:14842 E:14848 ||| NN
by  ||| S:14848 E:14851 ||| IN
SCF  ||| S:14851 E:14855 ||| NNP
Poppurified  ||| S:14855 E:14867 ||| NNP
from  ||| S:14867 E:14883 ||| IN
csn5  ||| S:14883 E:14888 ||| CD
mutants  ||| S:14888 E:14896 ||| NNS
( ||| S:14896 E:14897 ||| -LRB-
unpublished  ||| S:14897 E:14919 ||| JJ
observation ||| S:14919 E:14930 ||| NN
) ||| S:14930 E:14931 ||| -RRB-
.  ||| S:14931 E:14964 ||| .
Discussion  ||| S:14964 E:14983 ||| VBG
Our  ||| S:14983 E:14987 ||| PRP$
data  ||| S:14987 E:14992 ||| NNS
confirm  ||| S:14992 E:15000 ||| VBP
and  ||| S:15000 E:15004 ||| CC
extend  ||| S:15004 E:15011 ||| VB
the  ||| S:15011 E:15015 ||| DT
recently  ||| S:15015 E:15024 ||| RB
discovered  ||| S:15024 E:15043 ||| VBN
connection  ||| S:15043 E:15054 ||| NN
between  ||| S:15054 E:15062 ||| IN
CSN  ||| S:15062 E:15066 ||| NNP
and  ||| S:15066 E:15070 ||| CC
cullin  ||| S:15070 E:15077 ||| JJ
regulation  ||| S:15077 E:15088 ||| NN
[  ||| S:15088 E:15090 ||| -LRB-
10 ||| S:15090 E:15092 ||| CD
]  ||| S:15092 E:15094 ||| -RRB-
by  ||| S:15094 E:15105 ||| IN
showing  ||| S:15105 E:15113 ||| VBG
that  ||| S:15113 E:15118 ||| DT
deletion  ||| S:15118 E:15127 ||| NN
of  ||| S:15127 E:15130 ||| IN
four  ||| S:15130 E:15135 ||| CD
putative  ||| S:15135 E:15144 ||| JJ
CSN  ||| S:15144 E:15148 ||| NNP
subunits  ||| S:15148 E:15157 ||| NN
causes  ||| S:15157 E:15172 ||| VBZ
accumulation  ||| S:15172 E:15185 ||| VBN
of  ||| S:15185 E:15188 ||| IN
Pcu3p  ||| S:15188 E:15194 ||| CD
in  ||| S:15194 E:15197 ||| IN
the  ||| S:15197 E:15201 ||| DT
neddylated  ||| S:15201 E:15212 ||| JJ
state  ||| S:15212 E:15218 ||| NN
( ||| S:15218 E:15219 ||| -LRB-
Fig.  ||| S:15219 E:15224 ||| NNP
2A ||| S:15224 E:15226 ||| NNP
) ||| S:15226 E:15227 ||| -RRB-
.  ||| S:15227 E:15237 ||| .
Co-elution  ||| S:15237 E:15248 ||| JJ
of  ||| S:15248 E:15251 ||| IN
these  ||| S:15251 E:15257 ||| DT
four  ||| S:15257 E:15262 ||| CD
proteins  ||| S:15262 E:15271 ||| NNS
in  ||| S:15271 E:15274 ||| IN
a  ||| S:15274 E:15276 ||| DT
550  ||| S:15276 E:15280 ||| CD
kDa  ||| S:15280 E:15284 ||| JJ
complex  ||| S:15284 E:15300 ||| NN
( ||| S:15300 E:15301 ||| -LRB-
Fig.  ||| S:15301 E:15306 ||| NNP
4B ||| S:15306 E:15308 ||| NNP
)  ||| S:15308 E:15310 ||| -RRB-
strongly  ||| S:15310 E:15319 ||| RB
suggests  ||| S:15319 E:15328 ||| VBZ
that  ||| S:15328 E:15333 ||| IN
they  ||| S:15333 E:15338 ||| PRP
represent  ||| S:15338 E:15348 ||| VBP
part  ||| S:15348 E:15353 ||| NN
of  ||| S:15353 E:15356 ||| IN
the  ||| S:15356 E:15377 ||| DT
S.  ||| S:15377 E:15380 ||| NNP
pombe  ||| S:15380 E:15386 ||| JJ
equivalent  ||| S:15386 E:15397 ||| NN
of  ||| S:15397 E:15400 ||| IN
the  ||| S:15400 E:15404 ||| DT
eight  ||| S:15404 E:15418 ||| CD
subunit  ||| S:15418 E:15426 ||| JJ
CSN  ||| S:15426 E:15430 ||| NNP
complex  ||| S:15430 E:15438 ||| NN
found  ||| S:15438 E:15444 ||| VBD
in  ||| S:15444 E:15447 ||| IN
higher  ||| S:15447 E:15454 ||| JJR
eukaryotes  ||| S:15454 E:15465 ||| NNS
[  ||| S:15465 E:15467 ||| -LRB-
18 ||| S:15467 E:15469 ||| CD
,  ||| S:15469 E:15471 ||| ,
19 ||| S:15471 E:15473 ||| CD
,  ||| S:15473 E:15483 ||| ,
20 ||| S:15483 E:15485 ||| CD
] ||| S:15485 E:15486 ||| -RRB-
.  ||| S:15486 E:15488 ||| .
Thus ||| S:15488 E:15492 ||| RB
,  ||| S:15492 E:15494 ||| ,
cullin  ||| S:15494 E:15501 ||| JJ
regulation  ||| S:15501 E:15512 ||| NN
through  ||| S:15512 E:15520 ||| IN
modulation  ||| S:15520 E:15531 ||| NN
of  ||| S:15531 E:15534 ||| IN
the  ||| S:15534 E:15546 ||| DT
balance  ||| S:15546 E:15554 ||| NN
of  ||| S:15554 E:15557 ||| IN
Ned8p  ||| S:15557 E:15563 ||| CD
modification  ||| S:15563 E:15576 ||| NN
appears  ||| S:15576 E:15584 ||| VBZ
to  ||| S:15584 E:15587 ||| TO
require  ||| S:15587 E:15595 ||| VB
the  ||| S:15595 E:15599 ||| DT
entire  ||| S:15599 E:15614 ||| JJ
CSN  ||| S:15614 E:15618 ||| NNP
complex ||| S:15618 E:15625 ||| NN
.  ||| S:15625 E:15635 ||| .
Our  ||| S:15635 E:15639 ||| PRP$
study  ||| S:15639 E:15645 ||| NN
also  ||| S:15645 E:15650 ||| RB
provides  ||| S:15650 E:15659 ||| VBZ
some  ||| S:15659 E:15664 ||| DT
insight  ||| S:15664 E:15672 ||| NN
into  ||| S:15672 E:15677 ||| IN
the  ||| S:15677 E:15681 ||| DT
role  ||| S:15681 E:15686 ||| NN
of  ||| S:15686 E:15697 ||| IN
deneddylation  ||| S:15697 E:15711 ||| NN
in  ||| S:15711 E:15714 ||| IN
cullin  ||| S:15714 E:15721 ||| JJ
function ||| S:15721 E:15729 ||| NN
,  ||| S:15729 E:15731 ||| ,
as  ||| S:15731 E:15734 ||| IN
we  ||| S:15734 E:15737 ||| PRP
were  ||| S:15737 E:15742 ||| VBD
able  ||| S:15742 E:15747 ||| JJ
to  ||| S:15747 E:15750 ||| TO
create  ||| S:15750 E:15765 ||| VB
a  ||| S:15765 E:15767 ||| DT
situation  ||| S:15767 E:15777 ||| NN
in  ||| S:15777 E:15780 ||| IN
which  ||| S:15780 E:15786 ||| WDT
Pcu1p  ||| S:15786 E:15792 ||| NNP
and  ||| S:15792 E:15796 ||| CC
Pcu3p  ||| S:15796 E:15802 ||| NNP
are  ||| S:15802 E:15806 ||| VBP
fully  ||| S:15806 E:15812 ||| RB
neddylated  ||| S:15812 E:15832 ||| VBN
in  ||| S:15832 E:15835 ||| IN
vivo  ||| S:15835 E:15840 ||| NNS
( ||| S:15840 E:15841 ||| -LRB-
ref  ||| S:15841 E:15845 ||| FW
[  ||| S:15845 E:15847 ||| -LRB-
10 ||| S:15847 E:15849 ||| CD
]  ||| S:15849 E:15851 ||| -RRB-
and  ||| S:15851 E:15855 ||| CC
data  ||| S:15855 E:15860 ||| NNS
presented  ||| S:15860 E:15878 ||| VBD
here ||| S:15878 E:15882 ||| RB
) ||| S:15882 E:15883 ||| -RRB-
.  ||| S:15883 E:15885 ||| .
Deletion  ||| S:15885 E:15894 ||| NNP
of  ||| S:15894 E:15906 ||| IN
pcu1  ||| S:15906 E:15911 ||| NNP
and  ||| S:15911 E:15924 ||| CC
pcu3  ||| S:15924 E:15929 ||| CD
results  ||| S:15929 E:15937 ||| NNS
either  ||| S:15937 E:15944 ||| CC
in  ||| S:15944 E:15947 ||| IN
lethality  ||| S:15947 E:15957 ||| NN
or  ||| S:15957 E:15968 ||| CC
in  ||| S:15968 E:15971 ||| IN
severe  ||| S:15971 E:15978 ||| JJ
growth  ||| S:15978 E:15985 ||| NN
retardation ||| S:15985 E:15996 ||| NN
,  ||| S:15996 E:15998 ||| ,
respectively  ||| S:15998 E:16011 ||| RB
[  ||| S:16011 E:16013 ||| -LRB-
6 ||| S:16013 E:16014 ||| CD
] ||| S:16014 E:16015 ||| -RRB-
.  ||| S:16015 E:16017 ||| .
The  ||| S:16017 E:16021 ||| DT
normal  ||| S:16021 E:16036 ||| JJ
growth  ||| S:16036 E:16043 ||| NN
behavior  ||| S:16043 E:16052 ||| NN
of  ||| S:16052 E:16064 ||| IN
csn3  ||| S:16064 E:16069 ||| NNP
,  ||| S:16069 E:16080 ||| ,
4  ||| S:16080 E:16082 ||| CD
,  ||| S:16082 E:16084 ||| ,
and  ||| S:16084 E:16097 ||| CC
5  ||| S:16097 E:16099 ||| CD
mutants  ||| S:16099 E:16107 ||| NNS
( ||| S:16107 E:16108 ||| -LRB-
Fig.  ||| S:16108 E:16113 ||| NNP
2C ||| S:16113 E:16115 ||| NNP
,  ||| S:16115 E:16117 ||| ,
2D ||| S:16117 E:16119 ||| CD
) ||| S:16119 E:16120 ||| -RRB-
,  ||| S:16120 E:16122 ||| ,
where  ||| S:16122 E:16128 ||| WRB
both  ||| S:16128 E:16141 ||| DT
cullins  ||| S:16141 E:16149 ||| NNS
seem  ||| S:16149 E:16154 ||| VBP
constitutively  ||| S:16154 E:16169 ||| JJ
neddylated ||| S:16169 E:16179 ||| NN
,  ||| S:16179 E:16181 ||| ,
argues  ||| S:16181 E:16188 ||| VBZ
against  ||| S:16188 E:16196 ||| IN
a  ||| S:16196 E:16206 ||| DT
critical  ||| S:16206 E:16215 ||| JJ
role  ||| S:16215 E:16220 ||| NN
for  ||| S:16220 E:16224 ||| IN
dynamic  ||| S:16224 E:16232 ||| JJ
cycles  ||| S:16232 E:16239 ||| NNS
of  ||| S:16239 E:16242 ||| IN
neddylation  ||| S:16242 E:16254 ||| NN
and  ||| S:16254 E:16266 ||| CC
deneddylation  ||| S:16266 E:16280 ||| NN
in  ||| S:16280 E:16283 ||| IN
cullin  ||| S:16283 E:16290 ||| JJ
function  ||| S:16290 E:16299 ||| NN
in  ||| S:16299 E:16302 ||| IN
fission  ||| S:16302 E:16310 ||| JJ
yeast ||| S:16310 E:16315 ||| NN
.  ||| S:16315 E:16325 ||| .
Consistent  ||| S:16325 E:16336 ||| JJ
with  ||| S:16336 E:16341 ||| IN
this  ||| S:16341 E:16346 ||| DT
notion ||| S:16346 E:16352 ||| NN
,  ||| S:16352 E:16354 ||| ,
the  ||| S:16354 E:16358 ||| DT
subcellular  ||| S:16358 E:16370 ||| JJ
localization  ||| S:16370 E:16391 ||| NN
of  ||| S:16391 E:16394 ||| IN
Pcu3p  ||| S:16394 E:16400 ||| NNP
and  ||| S:16400 E:16404 ||| CC
Pcu1p  ||| S:16404 E:16410 ||| NNP
were  ||| S:16410 E:16415 ||| VBD
unaffected  ||| S:16415 E:16426 ||| VBN
by  ||| S:16426 E:16429 ||| IN
mutations  ||| S:16429 E:16439 ||| NNS
in  ||| S:16439 E:16442 ||| IN
CSN  ||| S:16442 E:16454 ||| NNP
( ||| S:16454 E:16455 ||| -LRB-
Fig.  ||| S:16455 E:16460 ||| CD
5 ||| S:16460 E:16461 ||| CD
)  ||| S:16461 E:16463 ||| -RRB-
[  ||| S:16463 E:16465 ||| -LRB-
10 ||| S:16465 E:16467 ||| CD
] ||| S:16467 E:16468 ||| -RRB-
.  ||| S:16468 E:16470 ||| .
Instead ||| S:16470 E:16477 ||| RB
,  ||| S:16477 E:16479 ||| ,
neddylated  ||| S:16479 E:16490 ||| JJ
Pcu3p  ||| S:16490 E:16496 ||| NN
and  ||| S:16496 E:16500 ||| CC
Pcu1p  ||| S:16500 E:16514 ||| CD
purified  ||| S:16514 E:16523 ||| NN
from  ||| S:16523 E:16537 ||| IN
csn  ||| S:16537 E:16541 ||| FW
mutant  ||| S:16541 E:16548 ||| FW
cell  ||| S:16548 E:16553 ||| FW
extract  ||| S:16553 E:16561 ||| FW
exhibit  ||| S:16561 E:16577 ||| FW
increased  ||| S:16577 E:16587 ||| FW
ubiquitin  ||| S:16587 E:16597 ||| FW
ligase  ||| S:16597 E:16604 ||| FW
activity  ||| S:16604 E:16622 ||| FW
in  ||| S:16622 E:16625 ||| FW
vitro  ||| S:16625 E:16631 ||| FW
( ||| S:16631 E:16632 ||| -LRB-
Fig.  ||| S:16632 E:16637 ||| NNP
6B ||| S:16637 E:16639 ||| NNP
)  ||| S:16639 E:16641 ||| -RRB-
[  ||| S:16641 E:16643 ||| -LRB-
10 ||| S:16643 E:16645 ||| CD
] ||| S:16645 E:16646 ||| -RRB-
.  ||| S:16646 E:16648 ||| .
Thus ||| S:16648 E:16652 ||| RB
,  ||| S:16652 E:16654 ||| ,
CSN  ||| S:16654 E:16666 ||| NNP
may  ||| S:16666 E:16670 ||| MD
exert  ||| S:16670 E:16676 ||| VB
negative  ||| S:16676 E:16685 ||| JJ
control  ||| S:16685 E:16693 ||| NN
on  ||| S:16693 E:16696 ||| IN
Pcu1p  ||| S:16696 E:16702 ||| NNP
and  ||| S:16702 E:16706 ||| CC
Pcu3p  ||| S:16706 E:16712 ||| CD
by  ||| S:16712 E:16715 ||| IN
promoting  ||| S:16715 E:16733 ||| VBG
their  ||| S:16733 E:16739 ||| PRP$
deneddylation ||| S:16739 E:16752 ||| NN
.  ||| S:16752 E:16754 ||| .
However ||| S:16754 E:16761 ||| RB
,  ||| S:16761 E:16763 ||| ,
while  ||| S:16763 E:16769 ||| IN
mutation  ||| S:16769 E:16778 ||| NN
of  ||| S:16778 E:16790 ||| IN
csn5  ||| S:16790 E:16795 ||| NNP
caused  ||| S:16795 E:16802 ||| VBD
a  ||| S:16802 E:16804 ||| DT
modest  ||| S:16804 E:16811 ||| JJ
two-fold  ||| S:16811 E:16828 ||| JJ
increase  ||| S:16828 E:16837 ||| NN
in  ||| S:16837 E:16840 ||| IN
the  ||| S:16840 E:16844 ||| DT
steady  ||| S:16844 E:16851 ||| JJ
state  ||| S:16851 E:16857 ||| NN
fraction  ||| S:16857 E:16866 ||| NN
of  ||| S:16866 E:16869 ||| IN
neddylated  ||| S:16869 E:16880 ||| CD
Pcu3p  ||| S:16880 E:16894 ||| CD
( ||| S:16894 E:16895 ||| -LRB-
Fig.  ||| S:16895 E:16900 ||| NNP
2A ||| S:16900 E:16902 ||| NNP
) ||| S:16902 E:16903 ||| -RRB-
,  ||| S:16903 E:16905 ||| ,
Pcu3p-associated  ||| S:16905 E:16922 ||| FW
ubiquitin  ||| S:16922 E:16932 ||| FW
ligase  ||| S:16932 E:16939 ||| FW
activity  ||| S:16939 E:16956 ||| NN
recovered  ||| S:16956 E:16966 ||| VBD
from  ||| S:16966 E:16971 ||| IN
this  ||| S:16971 E:16976 ||| DT
mutant  ||| S:16976 E:16983 ||| NN
showed  ||| S:16983 E:16990 ||| VBD
a  ||| S:16990 E:16992 ||| DT
much  ||| S:16992 E:16997 ||| RB
more  ||| S:16997 E:17002 ||| RBR
dramatic  ||| S:17002 E:17019 ||| JJ
increase  ||| S:17019 E:17028 ||| NN
( ||| S:17028 E:17029 ||| -LRB-
Fig.  ||| S:17029 E:17034 ||| NNP
6C ||| S:17034 E:17036 ||| NNP
) ||| S:17036 E:17037 ||| -RRB-
.  ||| S:17037 E:17039 ||| .
This  ||| S:17039 E:17044 ||| DT
suggests  ||| S:17044 E:17053 ||| VBZ
the  ||| S:17053 E:17057 ||| DT
possibility  ||| S:17057 E:17069 ||| NN
that  ||| S:17069 E:17074 ||| IN
CSN  ||| S:17074 E:17086 ||| NNP
represses  ||| S:17086 E:17096 ||| VBD
Pcu3p  ||| S:17096 E:17102 ||| CD
activity  ||| S:17102 E:17111 ||| NN
by  ||| S:17111 E:17114 ||| IN
other  ||| S:17114 E:17120 ||| JJ
mechanisms ||| S:17120 E:17130 ||| NNS
,  ||| S:17130 E:17132 ||| ,
in  ||| S:17132 E:17135 ||| IN
addition  ||| S:17135 E:17152 ||| NN
to  ||| S:17152 E:17155 ||| TO
its  ||| S:17155 E:17159 ||| PRP$
control  ||| S:17159 E:17167 ||| NN
of  ||| S:17167 E:17170 ||| IN
neddylation ||| S:17170 E:17181 ||| NN
.  ||| S:17181 E:17183 ||| .
Further  ||| S:17183 E:17191 ||| JJ
experiments  ||| S:17191 E:17203 ||| NNS
are  ||| S:17203 E:17215 ||| VBP
required  ||| S:17215 E:17224 ||| VBN
to  ||| S:17224 E:17227 ||| TO
determine  ||| S:17227 E:17237 ||| VB
whether  ||| S:17237 E:17245 ||| IN
recombinant  ||| S:17245 E:17257 ||| JJ
Csn5p  ||| S:17257 E:17263 ||| NN
or  ||| S:17263 E:17266 ||| CC
purified  ||| S:17266 E:17283 ||| JJ
CSN  ||| S:17283 E:17287 ||| NNP
complex  ||| S:17287 E:17295 ||| NN
can  ||| S:17295 E:17299 ||| MD
inhibit  ||| S:17299 E:17307 ||| VB
Pcu3p-associated  ||| S:17307 E:17324 ||| CD
ubiquitin  ||| S:17324 E:17334 ||| CD
ligase  ||| S:17334 E:17349 ||| JJ
activity ||| S:17349 E:17357 ||| NN
.  ||| S:17357 E:17367 ||| .
Lyapina  ||| S:17367 E:17384 ||| NNP
et  ||| S:17384 E:17387 ||| NNP
al.  ||| S:17387 E:17391 ||| NNP
recently  ||| S:17391 E:17400 ||| RB
provided  ||| S:17400 E:17409 ||| VBN
evidence  ||| S:17409 E:17418 ||| NN
for  ||| S:17418 E:17430 ||| IN
a  ||| S:17430 E:17432 ||| DT
cullin  ||| S:17432 E:17439 ||| JJ
deneddylating  ||| S:17439 E:17453 ||| JJ
activity  ||| S:17453 E:17462 ||| NN
of  ||| S:17462 E:17465 ||| IN
CSN  ||| S:17465 E:17469 ||| NNP
by  ||| S:17469 E:17472 ||| IN
demonstrating  ||| S:17472 E:17494 ||| VBG
that  ||| S:17494 E:17499 ||| IN
a  ||| S:17499 E:17501 ||| DT
partially  ||| S:17501 E:17511 ||| RB
purified  ||| S:17511 E:17520 ||| JJ
preparation  ||| S:17520 E:17532 ||| NN
of  ||| S:17532 E:17535 ||| IN
the  ||| S:17535 E:17539 ||| DT
pig  ||| S:17539 E:17543 ||| NN
CSN  ||| S:17543 E:17547 ||| NNP
can  ||| S:17547 E:17559 ||| MD
deneddylate  ||| S:17559 E:17571 ||| VB
the  ||| S:17571 E:17575 ||| DT
fission  ||| S:17575 E:17583 ||| FW
yeast  ||| S:17583 E:17589 ||| FW
cullin  ||| S:17589 E:17596 ||| FW
Pcu1p  ||| S:17596 E:17611 ||| FW
in  ||| S:17611 E:17614 ||| FW
vitro  ||| S:17614 E:17620 ||| FW
[  ||| S:17620 E:17622 ||| -LRB-
10 ||| S:17622 E:17624 ||| CD
] ||| S:17624 E:17625 ||| -RRB-
.  ||| S:17625 E:17627 ||| .
The  ||| S:17627 E:17631 ||| DT
results  ||| S:17631 E:17639 ||| NNS
presented  ||| S:17639 E:17657 ||| VBD
here  ||| S:17657 E:17662 ||| RB
eliminate  ||| S:17662 E:17672 ||| VB
the  ||| S:17672 E:17676 ||| DT
attractive  ||| S:17676 E:17687 ||| JJ
hypothesis  ||| S:17687 E:17698 ||| NN
that  ||| S:17698 E:17703 ||| IN
the  ||| S:17703 E:17707 ||| DT
cysteine  ||| S:17707 E:17724 ||| JJ
box  ||| S:17724 E:17728 ||| NN
in  ||| S:17728 E:17731 ||| IN
Csn5p ||| S:17731 E:17736 ||| NNP
,  ||| S:17736 E:17738 ||| ,
which  ||| S:17738 E:17744 ||| WDT
is  ||| S:17744 E:17747 ||| VBZ
conserved  ||| S:17747 E:17757 ||| VBN
in  ||| S:17757 E:17760 ||| IN
numerous  ||| S:17760 E:17777 ||| JJ
deubiquitylating  ||| S:17777 E:17794 ||| JJ
enzymes  ||| S:17794 E:17802 ||| NNS
[  ||| S:17802 E:17804 ||| -LRB-
23 ||| S:17804 E:17806 ||| CD
] ||| S:17806 E:17807 ||| -RRB-
,  ||| S:17807 E:17809 ||| ,
harbors  ||| S:17809 E:17817 ||| VBZ
a  ||| S:17817 E:17819 ||| DT
critical  ||| S:17819 E:17828 ||| JJ
activity  ||| S:17828 E:17845 ||| NN
for  ||| S:17845 E:17849 ||| IN
deneddylation  ||| S:17849 E:17863 ||| NNS
( ||| S:17863 E:17864 ||| -LRB-
Fig.  ||| S:17864 E:17869 ||| NNP
3A ||| S:17869 E:17871 ||| NNP
) ||| S:17871 E:17872 ||| -RRB-
.  ||| S:17872 E:17874 ||| .
In  ||| S:17874 E:17877 ||| IN
addition ||| S:17877 E:17885 ||| NN
,  ||| S:17885 E:17887 ||| ,
recombinant  ||| S:17887 E:17899 ||| JJ
Csn5p  ||| S:17899 E:17913 ||| NN
failed  ||| S:17913 E:17920 ||| VBD
to  ||| S:17920 E:17923 ||| TO
deneddylate  ||| S:17923 E:17935 ||| VB
Pcu1p  ||| S:17935 E:17941 ||| NNP
and  ||| S:17941 E:17945 ||| CC
Pcu3p  ||| S:17945 E:17960 ||| CD
in  ||| S:17960 E:17963 ||| IN
vitro  ||| S:17963 E:17969 ||| NNS
( ||| S:17969 E:17970 ||| -LRB-
unpublished  ||| S:17970 E:17982 ||| JJ
observation ||| S:17982 E:17993 ||| NN
) ||| S:17993 E:17994 ||| -RRB-
.  ||| S:17994 E:18004 ||| .
Our  ||| S:18004 E:18008 ||| PRP$
finding  ||| S:18008 E:18016 ||| NN
that  ||| S:18016 E:18021 ||| IN
hyperneddylated  ||| S:18021 E:18037 ||| JJ
Pcu3p  ||| S:18037 E:18043 ||| NN
and  ||| S:18043 E:18047 ||| CC
Pcu1p  ||| S:18047 E:18053 ||| CD
accumulate  ||| S:18053 E:18072 ||| NN
in  ||| S:18072 E:18075 ||| IN
all  ||| S:18075 E:18088 ||| DT
csn  ||| S:18088 E:18092 ||| FW
mutants  ||| S:18092 E:18100 ||| FW
tested  ||| S:18100 E:18107 ||| FW
( ||| S:18107 E:18108 ||| -LRB-
Fig.  ||| S:18108 E:18113 ||| NNP
2A ||| S:18113 E:18115 ||| NNP
,  ||| S:18115 E:18117 ||| ,
and  ||| S:18117 E:18121 ||| CC
data  ||| S:18121 E:18134 ||| NNS
not  ||| S:18134 E:18138 ||| RB
shown ||| S:18138 E:18143 ||| VBN
) ||| S:18143 E:18144 ||| -RRB-
,  ||| S:18144 E:18146 ||| ,
also  ||| S:18146 E:18151 ||| RB
suggests  ||| S:18151 E:18160 ||| VBZ
that  ||| S:18160 E:18165 ||| DT
control  ||| S:18165 E:18173 ||| NN
of  ||| S:18173 E:18176 ||| IN
cullin  ||| S:18176 E:18191 ||| JJ
neddylation  ||| S:18191 E:18203 ||| JJ
results  ||| S:18203 E:18211 ||| NNS
from  ||| S:18211 E:18216 ||| IN
cooperation  ||| S:18216 E:18228 ||| NN
of  ||| S:18228 E:18231 ||| IN
multiple  ||| S:18231 E:18240 ||| JJ
CSN  ||| S:18240 E:18252 ||| NN
components  ||| S:18252 E:18263 ||| NNS
rather  ||| S:18263 E:18270 ||| RB
than  ||| S:18270 E:18275 ||| IN
from  ||| S:18275 E:18280 ||| IN
the  ||| S:18280 E:18284 ||| DT
activity  ||| S:18284 E:18293 ||| NN
of  ||| S:18293 E:18296 ||| IN
a  ||| S:18296 E:18298 ||| DT
single  ||| S:18298 E:18313 ||| JJ
catalytic  ||| S:18313 E:18323 ||| JJ
subunit ||| S:18323 E:18330 ||| NN
.  ||| S:18330 E:18332 ||| .
The  ||| S:18332 E:18336 ||| DT
CSN  ||| S:18336 E:18340 ||| NNP
complex  ||| S:18340 E:18348 ||| NN
may ||| S:18348 E:18351 ||| MD
,  ||| S:18351 E:18353 ||| ,
for  ||| S:18353 E:18357 ||| IN
example ||| S:18357 E:18364 ||| NN
,  ||| S:18364 E:18366 ||| ,
serve  ||| S:18366 E:18380 ||| VB
as  ||| S:18380 E:18383 ||| IN
a  ||| S:18383 E:18385 ||| DT
platform  ||| S:18385 E:18394 ||| NN
for  ||| S:18394 E:18398 ||| IN
recruitment  ||| S:18398 E:18410 ||| NN
of  ||| S:18410 E:18413 ||| IN
a  ||| S:18413 E:18415 ||| DT
separate  ||| S:18415 E:18424 ||| JJ
deneddylating  ||| S:18424 E:18446 ||| JJ
enzyme ||| S:18446 E:18452 ||| NN
.  ||| S:18452 E:18454 ||| .
A  ||| S:18454 E:18456 ||| DT
human  ||| S:18456 E:18462 ||| JJ
NEDD8-processing  ||| S:18462 E:18479 ||| CD
isopeptidase  ||| S:18479 E:18492 ||| NN
has  ||| S:18492 E:18496 ||| VBZ
been  ||| S:18496 E:18509 ||| VBN
described  ||| S:18509 E:18519 ||| VBN
previously  ||| S:18519 E:18530 ||| RB
[  ||| S:18530 E:18532 ||| -LRB-
31 ||| S:18532 E:18534 ||| CD
] ||| S:18534 E:18535 ||| -RRB-
.  ||| S:18535 E:18537 ||| .
The  ||| S:18537 E:18541 ||| DT
potential  ||| S:18541 E:18551 ||| JJ
role  ||| S:18551 E:18556 ||| NN
of  ||| S:18556 E:18559 ||| IN
CSN  ||| S:18559 E:18563 ||| NNP
as  ||| S:18563 E:18566 ||| IN
an  ||| S:18566 E:18577 ||| DT
organizing  ||| S:18577 E:18588 ||| JJ
center  ||| S:18588 E:18595 ||| NN
for  ||| S:18595 E:18599 ||| IN
certain  ||| S:18599 E:18607 ||| JJ
enzymatic  ||| S:18607 E:18617 ||| JJ
activities  ||| S:18617 E:18628 ||| NNS
may  ||| S:18628 E:18632 ||| MD
not  ||| S:18632 E:18644 ||| RB
be  ||| S:18644 E:18647 ||| VB
restricted  ||| S:18647 E:18658 ||| VBN
to  ||| S:18658 E:18661 ||| TO
the  ||| S:18661 E:18665 ||| DT
control  ||| S:18665 E:18673 ||| NN
of  ||| S:18673 E:18676 ||| IN
cullin  ||| S:18676 E:18683 ||| JJ
neddylation ||| S:18683 E:18694 ||| NN
,  ||| S:18694 E:18696 ||| ,
as  ||| S:18696 E:18699 ||| IN
CSN  ||| S:18699 E:18711 ||| NNP
was  ||| S:18711 E:18715 ||| VBD
also  ||| S:18715 E:18720 ||| RB
shown  ||| S:18720 E:18726 ||| VBN
to  ||| S:18726 E:18729 ||| TO
mediate  ||| S:18729 E:18737 ||| VB
phosphorylation  ||| S:18737 E:18753 ||| VBN
of  ||| S:18753 E:18756 ||| IN
c-JUN ||| S:18756 E:18761 ||| NNP
,  ||| S:18761 E:18763 ||| ,
IkBa ||| S:18763 E:18767 ||| NNP
,  ||| S:18767 E:18777 ||| ,
and  ||| S:18777 E:18781 ||| CC
p53  ||| S:18781 E:18785 ||| NN
by  ||| S:18785 E:18788 ||| IN
a  ||| S:18788 E:18790 ||| DT
tightly  ||| S:18790 E:18798 ||| RB
associated  ||| S:18798 E:18809 ||| VBN
kinase ||| S:18809 E:18815 ||| NNS
( ||| S:18815 E:18816 ||| -LRB-
s ||| S:18816 E:18817 ||| LS
)  ||| S:18817 E:18819 ||| -RRB-
[  ||| S:18819 E:18821 ||| -LRB-
12 ||| S:18821 E:18823 ||| CD
,  ||| S:18823 E:18825 ||| ,
19 ||| S:18825 E:18827 ||| CD
] ||| S:18827 E:18828 ||| -RRB-
.  ||| S:18828 E:18838 ||| .
So  ||| S:18838 E:18841 ||| RB
far ||| S:18841 E:18844 ||| RB
,  ||| S:18844 E:18846 ||| ,
we  ||| S:18846 E:18849 ||| PRP
were  ||| S:18849 E:18854 ||| VBD
unable  ||| S:18854 E:18861 ||| JJ
to  ||| S:18861 E:18864 ||| TO
obtain  ||| S:18864 E:18871 ||| VB
deneddylation  ||| S:18871 E:18885 ||| VBN
of  ||| S:18885 E:18896 ||| IN
Pcu3p-13Myc  ||| S:18896 E:18917 ||| CD
in  ||| S:18917 E:18920 ||| IN
vitro  ||| S:18920 E:18926 ||| NN
by  ||| S:18926 E:18929 ||| IN
partially  ||| S:18929 E:18939 ||| FW
purified  ||| S:18939 E:18948 ||| FW
CSN  ||| S:18948 E:18960 ||| FW
preparations  ||| S:18960 E:18973 ||| FW
active  ||| S:18973 E:18980 ||| JJ
in  ||| S:18980 E:18983 ||| IN
deneddylation  ||| S:18983 E:18997 ||| NN
of  ||| S:18997 E:19000 ||| IN
Pcu1p-13Myc  ||| S:19000 E:19012 ||| NNP
( ||| S:19012 E:19013 ||| -LRB-
data  ||| S:19013 E:19026 ||| NNS
not  ||| S:19026 E:19030 ||| RB
shown ||| S:19030 E:19035 ||| VBN
) ||| S:19035 E:19036 ||| -RRB-
.  ||| S:19036 E:19038 ||| .
We  ||| S:19038 E:19041 ||| PRP
can  ||| S:19041 E:19045 ||| MD
therefore  ||| S:19045 E:19055 ||| RB
not  ||| S:19055 E:19059 ||| RB
exclude  ||| S:19059 E:19067 ||| VB
that  ||| S:19067 E:19072 ||| IN
CSN ||| S:19072 E:19075 ||| NNP
's  ||| S:19075 E:19078 ||| POS
role  ||| S:19078 E:19083 ||| NN
in  ||| S:19083 E:19094 ||| IN
the  ||| S:19094 E:19098 ||| DT
control  ||| S:19098 E:19106 ||| NN
of  ||| S:19106 E:19109 ||| IN
Pcu3p  ||| S:19109 E:19115 ||| CD
neddylation  ||| S:19115 E:19127 ||| NN
differs  ||| S:19127 E:19135 ||| VBZ
from  ||| S:19135 E:19140 ||| IN
its  ||| S:19140 E:19144 ||| PRP$
role  ||| S:19144 E:19157 ||| NN
established  ||| S:19157 E:19169 ||| VBN
for  ||| S:19169 E:19173 ||| IN
Pcu1p  ||| S:19173 E:19179 ||| NNP
[  ||| S:19179 E:19181 ||| -LRB-
10 ||| S:19181 E:19183 ||| CD
] ||| S:19183 E:19184 ||| -RRB-
.  ||| S:19184 E:19186 ||| .
For  ||| S:19186 E:19190 ||| IN
example ||| S:19190 E:19197 ||| NN
,  ||| S:19197 E:19199 ||| ,
binding  ||| S:19199 E:19207 ||| VBG
by  ||| S:19207 E:19210 ||| IN
CSN  ||| S:19210 E:19222 ||| NNP
could  ||| S:19222 E:19228 ||| MD
protect  ||| S:19228 E:19236 ||| VB
Pcu3p  ||| S:19236 E:19242 ||| CD
from  ||| S:19242 E:19247 ||| IN
the  ||| S:19247 E:19251 ||| DT
Ned8p-conjugating  ||| S:19251 E:19269 ||| CD
enzyme  ||| S:19269 E:19284 ||| CD
Ubc12p ||| S:19284 E:19290 ||| CD
,  ||| S:19290 E:19292 ||| ,
thus  ||| S:19292 E:19297 ||| RB
maintaining  ||| S:19297 E:19309 ||| VBG
a  ||| S:19309 E:19311 ||| DT
fraction  ||| S:19311 E:19320 ||| NN
of  ||| S:19320 E:19323 ||| IN
Pcu3p  ||| S:19323 E:19329 ||| CD
in  ||| S:19329 E:19332 ||| IN
a  ||| S:19332 E:19342 ||| DT
deneddylated  ||| S:19342 E:19355 ||| JJ
state ||| S:19355 E:19360 ||| NN
.  ||| S:19360 E:19362 ||| .
As  ||| S:19362 E:19365 ||| IN
this  ||| S:19365 E:19370 ||| DT
shield  ||| S:19370 E:19377 ||| NN
is  ||| S:19377 E:19380 ||| VBZ
experimentally  ||| S:19380 E:19403 ||| RB
removed  ||| S:19403 E:19411 ||| VBN
through  ||| S:19411 E:19419 ||| IN
deletion  ||| S:19419 E:19428 ||| NN
of  ||| S:19428 E:19431 ||| IN
CSN  ||| S:19431 E:19435 ||| NNP
subunits ||| S:19435 E:19443 ||| NN
,  ||| S:19443 E:19445 ||| ,
Pcu3p  ||| S:19445 E:19451 ||| NNP
may  ||| S:19451 E:19463 ||| MD
accumulate  ||| S:19463 E:19474 ||| VB
in  ||| S:19474 E:19477 ||| IN
the  ||| S:19477 E:19481 ||| DT
neddylated  ||| S:19481 E:19492 ||| JJ
state ||| S:19492 E:19497 ||| NN
.  ||| S:19497 E:19499 ||| .
In  ||| S:19499 E:19502 ||| IN
such  ||| S:19502 E:19507 ||| PDT
a  ||| S:19507 E:19509 ||| DT
scenario ||| S:19509 E:19517 ||| NN
,  ||| S:19517 E:19519 ||| ,
no  ||| S:19519 E:19530 ||| DT
enzymatic  ||| S:19530 E:19540 ||| JJ
activity  ||| S:19540 E:19549 ||| NN
of  ||| S:19549 E:19552 ||| IN
purified  ||| S:19552 E:19561 ||| JJ
CSN  ||| S:19561 E:19565 ||| NN
toward  ||| S:19565 E:19572 ||| IN
neddylated  ||| S:19572 E:19583 ||| JJ
Pcu3p  ||| S:19583 E:19597 ||| NN
would  ||| S:19597 E:19603 ||| MD
be  ||| S:19603 E:19606 ||| VB
expected  ||| S:19606 E:19624 ||| VBN
in  ||| S:19624 E:19627 ||| IN
vitro  ||| S:19627 E:19633 ||| NN
.  ||| S:19633 E:19643 ||| .
Finally ||| S:19643 E:19650 ||| RB
,  ||| S:19650 E:19652 ||| ,
our  ||| S:19652 E:19656 ||| PRP$
data  ||| S:19656 E:19661 ||| NNS
suggest  ||| S:19661 E:19669 ||| VBP
CSN  ||| S:19669 E:19673 ||| JJ
functions  ||| S:19673 E:19683 ||| NNS
in  ||| S:19683 E:19686 ||| IN
addition  ||| S:19686 E:19695 ||| NN
to  ||| S:19695 E:19706 ||| TO
cullin  ||| S:19706 E:19713 ||| VB
regulation  ||| S:19713 E:19724 ||| NN
that  ||| S:19724 E:19729 ||| WDT
are  ||| S:19729 E:19733 ||| VBP
not  ||| S:19733 E:19737 ||| RB
shared  ||| S:19737 E:19744 ||| VBN
by  ||| S:19744 E:19747 ||| IN
all  ||| S:19747 E:19751 ||| DT
individual  ||| S:19751 E:19770 ||| JJ
subunits ||| S:19770 E:19778 ||| NN
.  ||| S:19778 E:19780 ||| .
Out  ||| S:19780 E:19784 ||| RB
of  ||| S:19784 E:19787 ||| IN
the  ||| S:19787 E:19791 ||| DT
four  ||| S:19791 E:19796 ||| CD
mutants  ||| S:19796 E:19804 ||| NNS
tested ||| S:19804 E:19810 ||| VBN
,  ||| S:19810 E:19812 ||| ,
only  ||| S:19812 E:19826 ||| RB
csn1  ||| S:19826 E:19831 ||| RB
showed  ||| S:19831 E:19838 ||| VBD
the  ||| S:19838 E:19842 ||| DT
previously  ||| S:19842 E:19853 ||| RB
described  ||| S:19853 E:19871 ||| VBN
defect  ||| S:19871 E:19878 ||| NN
in  ||| S:19878 E:19881 ||| IN
S  ||| S:19881 E:19883 ||| NNP
phase  ||| S:19883 E:19889 ||| NN
progression  ||| S:19889 E:19901 ||| NNS
[  ||| S:19901 E:19903 ||| -LRB-
21 ||| S:19903 E:19905 ||| CD
]  ||| S:19905 E:19907 ||| -RRB-
( ||| S:19907 E:19908 ||| -LRB-
Fig.  ||| S:19908 E:19913 ||| NNP
2C ||| S:19913 E:19915 ||| NNP
,  ||| S:19915 E:19917 ||| ,
2D ||| S:19917 E:19919 ||| CD
) ||| S:19919 E:19920 ||| -RRB-
,  ||| S:19920 E:19922 ||| ,
thereby  ||| S:19922 E:19938 ||| RB
underscoring  ||| S:19938 E:19951 ||| VBG
the  ||| S:19951 E:19955 ||| DT
significance  ||| S:19955 E:19968 ||| NN
of  ||| S:19968 E:19971 ||| IN
our  ||| S:19971 E:19975 ||| PRP$
finding  ||| S:19975 E:19983 ||| NN
that  ||| S:19983 E:19988 ||| IN
all  ||| S:19988 E:19992 ||| DT
CSN  ||| S:19992 E:20004 ||| NNP
subunits  ||| S:20004 E:20013 ||| VBD
tested  ||| S:20013 E:20020 ||| VBN
here  ||| S:20020 E:20025 ||| RB
are  ||| S:20025 E:20029 ||| VBP
involved  ||| S:20029 E:20038 ||| VBN
in  ||| S:20038 E:20041 ||| IN
cullin  ||| S:20041 E:20048 ||| JJ
regulation ||| S:20048 E:20058 ||| NN
.  ||| S:20058 E:20060 ||| .
It  ||| S:20060 E:20071 ||| PRP
is  ||| S:20071 E:20074 ||| VBZ
likely  ||| S:20074 E:20081 ||| RB
that  ||| S:20081 E:20086 ||| IN
some  ||| S:20086 E:20091 ||| DT
subunits  ||| S:20091 E:20100 ||| NNS
have  ||| S:20100 E:20105 ||| VBP
very  ||| S:20105 E:20110 ||| RB
specialized  ||| S:20110 E:20130 ||| JJ
functions  ||| S:20130 E:20140 ||| NNS
within  ||| S:20140 E:20147 ||| IN
the  ||| S:20147 E:20151 ||| DT
complex ||| S:20151 E:20158 ||| NN
,  ||| S:20158 E:20160 ||| ,
while  ||| S:20160 E:20166 ||| IN
others  ||| S:20166 E:20173 ||| NNS
are  ||| S:20173 E:20177 ||| VBP
required  ||| S:20177 E:20186 ||| VBN
for  ||| S:20186 E:20198 ||| IN
its  ||| S:20198 E:20202 ||| PRP$
broader  ||| S:20202 E:20210 ||| JJR
activities  ||| S:20210 E:20221 ||| NNS
such  ||| S:20221 E:20226 ||| JJ
as  ||| S:20226 E:20229 ||| IN
control  ||| S:20229 E:20237 ||| NN
of  ||| S:20237 E:20240 ||| IN
cullin  ||| S:20240 E:20255 ||| JJ
neddylation ||| S:20255 E:20266 ||| NN
.  ||| S:20266 E:20268 ||| .
On  ||| S:20268 E:20271 ||| IN
the  ||| S:20271 E:20275 ||| DT
other  ||| S:20275 E:20281 ||| JJ
hand ||| S:20281 E:20285 ||| NN
,  ||| S:20285 E:20287 ||| ,
we  ||| S:20287 E:20290 ||| PRP
found  ||| S:20290 E:20296 ||| VBD
that  ||| S:20296 E:20301 ||| IN
a  ||| S:20301 E:20303 ||| DT
sizable  ||| S:20303 E:20319 ||| JJ
fraction  ||| S:20319 E:20328 ||| NN
of  ||| S:20328 E:20331 ||| IN
Csn5p  ||| S:20331 E:20337 ||| NNP
is  ||| S:20337 E:20340 ||| VBZ
dissociated  ||| S:20340 E:20352 ||| VBN
from  ||| S:20352 E:20357 ||| IN
the  ||| S:20357 E:20361 ||| DT
putative  ||| S:20361 E:20370 ||| JJ
CSN  ||| S:20370 E:20382 ||| NNP
holocomplex ||| S:20382 E:20393 ||| NN
,  ||| S:20393 E:20395 ||| ,
but  ||| S:20395 E:20399 ||| CC
enriched  ||| S:20399 E:20408 ||| NN
in  ||| S:20408 E:20411 ||| IN
a  ||| S:20411 E:20413 ||| DT
200  ||| S:20413 E:20417 ||| CD
kDa  ||| S:20417 E:20421 ||| JJ
assembly  ||| S:20421 E:20430 ||| NN
( ||| S:20430 E:20431 ||| -LRB-
Fig.  ||| S:20431 E:20436 ||| NNP
4B ||| S:20436 E:20438 ||| NNP
) ||| S:20438 E:20439 ||| -RRB-
.  ||| S:20439 E:20449 ||| .
It  ||| S:20449 E:20452 ||| PRP
thus  ||| S:20452 E:20457 ||| RB
appears  ||| S:20457 E:20465 ||| VBZ
that  ||| S:20465 E:20470 ||| DT
part  ||| S:20470 E:20475 ||| NN
of  ||| S:20475 E:20478 ||| IN
the  ||| S:20478 E:20482 ||| DT
diversification  ||| S:20482 E:20498 ||| NN
of  ||| S:20498 E:20501 ||| IN
CSN  ||| S:20501 E:20513 ||| NNP
function  ||| S:20513 E:20522 ||| NN
may  ||| S:20522 E:20526 ||| MD
arise  ||| S:20526 E:20532 ||| VB
from  ||| S:20532 E:20537 ||| IN
formation  ||| S:20537 E:20547 ||| NN
of  ||| S:20547 E:20550 ||| IN
smaller  ||| S:20550 E:20566 ||| JJR
subcomplexes ||| S:20566 E:20578 ||| NN
.  ||| S:20578 E:20602 ||| .
Conclusions  ||| S:20602 E:20622 ||| VBG
Our  ||| S:20622 E:20626 ||| PRP$
study  ||| S:20626 E:20632 ||| NN
reveals  ||| S:20632 E:20640 ||| VBZ
a  ||| S:20640 E:20642 ||| DT
general  ||| S:20642 E:20650 ||| JJ
role  ||| S:20650 E:20655 ||| NN
of  ||| S:20655 E:20658 ||| IN
the  ||| S:20658 E:20671 ||| DT
S.  ||| S:20671 E:20674 ||| NNP
pombe  ||| S:20674 E:20680 ||| VBD
CSN  ||| S:20680 E:20684 ||| NNP
complex  ||| S:20684 E:20692 ||| NN
in  ||| S:20692 E:20695 ||| IN
the  ||| S:20695 E:20699 ||| DT
control  ||| S:20699 E:20715 ||| NN
of  ||| S:20715 E:20718 ||| IN
cullin  ||| S:20718 E:20725 ||| JJ
modification  ||| S:20725 E:20738 ||| NN
by  ||| S:20738 E:20741 ||| IN
Ned8p ||| S:20741 E:20746 ||| CD
.  ||| S:20746 E:20748 ||| .
Regardless  ||| S:20748 E:20759 ||| RB
of  ||| S:20759 E:20762 ||| IN
the  ||| S:20762 E:20766 ||| DT
exact  ||| S:20766 E:20780 ||| JJ
mechanism ||| S:20780 E:20789 ||| NN
,  ||| S:20789 E:20791 ||| ,
CSN  ||| S:20791 E:20795 ||| NNP
may  ||| S:20795 E:20799 ||| MD
regulate  ||| S:20799 E:20808 ||| VB
the  ||| S:20808 E:20812 ||| DT
activity  ||| S:20812 E:20821 ||| NN
of  ||| S:20821 E:20824 ||| IN
multiple  ||| S:20824 E:20833 ||| JJ
cullin  ||| S:20833 E:20848 ||| JJ
ubiquitin  ||| S:20848 E:20858 ||| JJ
ligases  ||| S:20858 E:20866 ||| NN
through  ||| S:20866 E:20874 ||| IN
counteracting  ||| S:20874 E:20888 ||| VBG
their  ||| S:20888 E:20894 ||| PRP$
stimulatory  ||| S:20894 E:20914 ||| JJ
Ned8p  ||| S:20914 E:20920 ||| CD
modification ||| S:20920 E:20932 ||| NN
.  ||| S:20932 E:20934 ||| .
Future  ||| S:20934 E:20941 ||| JJ
studies  ||| S:20941 E:20949 ||| NNS
will  ||| S:20949 E:20954 ||| MD
reveal  ||| S:20954 E:20961 ||| VB
whether  ||| S:20961 E:20969 ||| IN
some  ||| S:20969 E:20982 ||| DT
of  ||| S:20982 E:20985 ||| IN
the  ||| S:20985 E:20989 ||| DT
other  ||| S:20989 E:20995 ||| JJ
described  ||| S:20995 E:21005 ||| JJ
functions  ||| S:21005 E:21015 ||| NNS
of  ||| S:21015 E:21018 ||| IN
CSN  ||| S:21018 E:21022 ||| NNP
also  ||| S:21022 E:21027 ||| RB
involve  ||| S:21027 E:21043 ||| VB
post-translational  ||| S:21043 E:21062 ||| JJ
modification  ||| S:21062 E:21075 ||| NN
of  ||| S:21075 E:21078 ||| IN
regulatory  ||| S:21078 E:21089 ||| JJ
proteins  ||| S:21089 E:21098 ||| NNS
by  ||| S:21098 E:21109 ||| IN
ubiquitin-like  ||| S:21109 E:21124 ||| JJ
modifiers ||| S:21124 E:21133 ||| NN
.  ||| S:21133 E:21157 ||| .
Materials  ||| S:21157 E:21167 ||| NNS
and  ||| S:21167 E:21171 ||| CC
methods  ||| S:21171 E:21198 ||| NNS
Plasmids  ||| S:21198 E:21207 ||| NNP
and  ||| S:21207 E:21211 ||| CC
yeast  ||| S:21211 E:21217 ||| NN
strains  ||| S:21217 E:21246 ||| NNS
S.  ||| S:21246 E:21249 ||| NNP
pombe  ||| S:21249 E:21255 ||| NN
genes  ||| S:21255 E:21261 ||| NNS
for  ||| S:21261 E:21265 ||| IN
UBCs  ||| S:21265 E:21270 ||| JJ
and  ||| S:21270 E:21285 ||| CC
csn3  ||| S:21285 E:21290 ||| NNP
,  ||| S:21290 E:21303 ||| ,
4  ||| S:21303 E:21305 ||| CD
,  ||| S:21305 E:21307 ||| ,
and  ||| S:21307 E:21322 ||| CC
5  ||| S:21322 E:21324 ||| CD
were  ||| S:21324 E:21329 ||| VBD
identified  ||| S:21329 E:21340 ||| VBN
in  ||| S:21340 E:21343 ||| IN
the  ||| S:21343 E:21347 ||| DT
Sanger  ||| S:21347 E:21364 ||| NNP
Centre  ||| S:21364 E:21382 ||| NNP
S.  ||| S:21382 E:21385 ||| NNP
pombe  ||| S:21385 E:21391 ||| VBD
sequence  ||| S:21391 E:21400 ||| JJ
database  ||| S:21400 E:21409 ||| NN
based  ||| S:21409 E:21415 ||| VBN
on  ||| S:21415 E:21428 ||| IN
their  ||| S:21428 E:21434 ||| PRP$
homology  ||| S:21434 E:21443 ||| NN
to  ||| S:21443 E:21446 ||| TO
the  ||| S:21446 E:21450 ||| DT
respective  ||| S:21450 E:21461 ||| JJ
human  ||| S:21461 E:21467 ||| JJ
and  ||| S:21467 E:21471 ||| CC
budding  ||| S:21471 E:21479 ||| JJ
yeast  ||| S:21479 E:21495 ||| NN
proteins ||| S:21495 E:21503 ||| NNS
.  ||| S:21503 E:21505 ||| .
Complementary  ||| S:21505 E:21519 ||| NNP
DNAs  ||| S:21519 E:21524 ||| NNP
were  ||| S:21524 E:21529 ||| VBD
amplified  ||| S:21529 E:21539 ||| VBN
by  ||| S:21539 E:21542 ||| IN
PCR  ||| S:21542 E:21546 ||| NNP
and  ||| S:21546 E:21560 ||| CC
subcloned  ||| S:21560 E:21570 ||| NN
into  ||| S:21570 E:21575 ||| IN
pRep81.6xHis-Myc ||| S:21575 E:21591 ||| NNP
,  ||| S:21591 E:21593 ||| ,
pRep3.6xHis-Myc ||| S:21593 E:21608 ||| NNP
,  ||| S:21608 E:21610 ||| ,
or  ||| S:21610 E:21623 ||| CC
pRep4.HA ||| S:21623 E:21631 ||| NNP
.  ||| S:21631 E:21633 ||| .
Deletion  ||| S:21633 E:21642 ||| JJ
strains  ||| S:21642 E:21650 ||| NNS
and  ||| S:21650 E:21654 ||| CC
epitope-tagged  ||| S:21654 E:21669 ||| JJ
strains  ||| S:21669 E:21687 ||| NNS
were  ||| S:21687 E:21692 ||| VBD
constructed  ||| S:21692 E:21704 ||| VBN
by  ||| S:21704 E:21707 ||| IN
one-step  ||| S:21707 E:21716 ||| JJ
gene  ||| S:21716 E:21721 ||| NN
replacement  ||| S:21721 E:21733 ||| NN
using  ||| S:21733 E:21749 ||| VBG
PCR-generated  ||| S:21749 E:21763 ||| JJ
fragments  ||| S:21763 E:21773 ||| NNS
containing  ||| S:21773 E:21784 ||| VBG
kanamycin  ||| S:21784 E:21794 ||| NNS
or  ||| S:21794 E:21808 ||| CC
ura4  ||| S:21808 E:21813 ||| CD
cassettes  ||| S:21813 E:21823 ||| NNS
[  ||| S:21823 E:21825 ||| -LRB-
32 ||| S:21825 E:21827 ||| CD
] ||| S:21827 E:21828 ||| -RRB-
.  ||| S:21828 E:21830 ||| .
Growth  ||| S:21830 E:21837 ||| NN
media ||| S:21837 E:21842 ||| NNS
,  ||| S:21842 E:21854 ||| ,
flow  ||| S:21854 E:21859 ||| NN
cytometry ||| S:21859 E:21868 ||| NN
,  ||| S:21868 E:21870 ||| ,
and  ||| S:21870 E:21874 ||| CC
all  ||| S:21874 E:21878 ||| DT
other  ||| S:21878 E:21884 ||| JJ
relevant  ||| S:21884 E:21904 ||| JJ
S.  ||| S:21904 E:21907 ||| NNP
pombe  ||| S:21907 E:21913 ||| NN
techniques  ||| S:21913 E:21924 ||| NNS
were  ||| S:21924 E:21929 ||| VBD
described  ||| S:21929 E:21949 ||| VBN
previously  ||| S:21949 E:21960 ||| RB
[  ||| S:21960 E:21962 ||| -LRB-
33 ||| S:21962 E:21964 ||| CD
] ||| S:21964 E:21965 ||| -RRB-
.  ||| S:21965 E:21995 ||| .
Immunological  ||| S:21995 E:22009 ||| JJ
techniques  ||| S:22009 E:22030 ||| NNS
Protein  ||| S:22030 E:22038 ||| JJ
lysates  ||| S:22038 E:22046 ||| NN
were  ||| S:22046 E:22051 ||| VBD
prepared  ||| S:22051 E:22060 ||| VBN
by  ||| S:22060 E:22063 ||| IN
bead  ||| S:22063 E:22068 ||| JJ
lysis  ||| S:22068 E:22074 ||| NN
in  ||| S:22074 E:22077 ||| IN
a  ||| S:22077 E:22089 ||| DT
Fastprep  ||| S:22089 E:22098 ||| JJ
device  ||| S:22098 E:22105 ||| NN
( ||| S:22105 E:22106 ||| -LRB-
Bio  ||| S:22106 E:22110 ||| NNP
101 ||| S:22110 E:22113 ||| CD
)  ||| S:22113 E:22115 ||| -RRB-
in  ||| S:22115 E:22118 ||| IN
the  ||| S:22118 E:22122 ||| DT
presence  ||| S:22122 E:22131 ||| NN
of  ||| S:22131 E:22134 ||| IN
proteinase  ||| S:22134 E:22155 ||| JJ
inhibitors ||| S:22155 E:22165 ||| NN
,  ||| S:22165 E:22167 ||| ,
followed  ||| S:22167 E:22176 ||| VBN
by  ||| S:22176 E:22179 ||| IN
boiling  ||| S:22179 E:22187 ||| VBG
in  ||| S:22187 E:22190 ||| IN
SDS  ||| S:22190 E:22194 ||| NNP
sample  ||| S:22194 E:22201 ||| NN
buffer ||| S:22201 E:22207 ||| NN
.  ||| S:22207 E:22219 ||| .
Pip1p  ||| S:22219 E:22225 ||| NNP
and  ||| S:22225 E:22229 ||| CC
Pcu1p  ||| S:22229 E:22235 ||| NNP
were  ||| S:22235 E:22240 ||| VBD
detected  ||| S:22240 E:22249 ||| VBN
with  ||| S:22249 E:22254 ||| IN
affinity-purified  ||| S:22254 E:22282 ||| JJ
rabbit  ||| S:22282 E:22289 ||| JJ
antisera ||| S:22289 E:22297 ||| NN
.  ||| S:22297 E:22299 ||| .
Epitope-tagged  ||| S:22299 E:22314 ||| JJ
proteins  ||| S:22314 E:22323 ||| NNS
were  ||| S:22323 E:22328 ||| VBD
detected  ||| S:22328 E:22337 ||| VBN
by  ||| S:22337 E:22350 ||| IN
the  ||| S:22350 E:22354 ||| DT
monoclonal  ||| S:22354 E:22365 ||| JJ
antibodies  ||| S:22365 E:22376 ||| JJ
9E10  ||| S:22376 E:22381 ||| NN
and  ||| S:22381 E:22385 ||| CC
12CA5  ||| S:22385 E:22391 ||| RB
prepared  ||| S:22391 E:22400 ||| VBN
from  ||| S:22400 E:22415 ||| IN
hybridoma  ||| S:22415 E:22425 ||| JJ
supernatants ||| S:22425 E:22437 ||| NN
.  ||| S:22437 E:22449 ||| .
Cell  ||| S:22449 E:22454 ||| NN
lysates  ||| S:22454 E:22462 ||| NN
for  ||| S:22462 E:22466 ||| IN
immunoprecipitation  ||| S:22466 E:22486 ||| NN
were  ||| S:22486 E:22491 ||| VBD
prepared  ||| S:22491 E:22500 ||| VBN
by  ||| S:22500 E:22513 ||| IN
disrupting  ||| S:22513 E:22524 ||| JJ
cells  ||| S:22524 E:22530 ||| NNS
in  ||| S:22530 E:22533 ||| IN
immunoprecipitation  ||| S:22533 E:22553 ||| JJ
buffer  ||| S:22553 E:22560 ||| NN
( ||| S:22560 E:22561 ||| -LRB-
20  ||| S:22561 E:22564 ||| CD
mM  ||| S:22564 E:22577 ||| JJ
Tris ||| S:22577 E:22581 ||| NNP
/ ||| S:22581 E:22582 ||| NNP
HCl ||| S:22582 E:22585 ||| NNP
,  ||| S:22585 E:22587 ||| ,
pH  ||| S:22587 E:22590 ||| JJ
7.4 ||| S:22590 E:22593 ||| CD
;  ||| S:22593 E:22595 ||| :
150  ||| S:22595 E:22599 ||| CD
mM  ||| S:22599 E:22602 ||| JJ
NaCl ||| S:22602 E:22606 ||| NN
;  ||| S:22606 E:22608 ||| :
0.5  ||| S:22608 E:22612 ||| CD
%  ||| S:22612 E:22614 ||| NN
Triton  ||| S:22614 E:22621 ||| NNP
X-100 ||| S:22621 E:22626 ||| NNP
,  ||| S:22626 E:22628 ||| ,
10  ||| S:22628 E:22641 ||| CD
μg ||| S:22641 E:22643 ||| CD
/ ||| S:22643 E:22644 ||| CD
ml  ||| S:22644 E:22647 ||| JJ
leupeptin ||| S:22647 E:22656 ||| NN
,  ||| S:22656 E:22658 ||| ,
10  ||| S:22658 E:22661 ||| CD
μg ||| S:22661 E:22663 ||| CD
/ ||| S:22663 E:22664 ||| CD
ml  ||| S:22664 E:22667 ||| JJ
pepstatin ||| S:22667 E:22676 ||| NN
,  ||| S:22676 E:22678 ||| ,
5  ||| S:22678 E:22680 ||| CD
μg ||| S:22680 E:22682 ||| CD
/ ||| S:22682 E:22683 ||| CD
ml  ||| S:22683 E:22686 ||| JJ
aprotinin ||| S:22686 E:22695 ||| NN
,  ||| S:22695 E:22697 ||| ,
1  ||| S:22697 E:22709 ||| CD
mM  ||| S:22709 E:22712 ||| JJ
PMSF ||| S:22712 E:22716 ||| NNP
) ||| S:22716 E:22717 ||| -RRB-
.  ||| S:22717 E:22719 ||| .
Lysates  ||| S:22719 E:22727 ||| NNP
were  ||| S:22727 E:22732 ||| VBD
cleared  ||| S:22732 E:22740 ||| VBN
and  ||| S:22740 E:22744 ||| CC
precipitated  ||| S:22744 E:22757 ||| VBD
with  ||| S:22757 E:22762 ||| IN
the  ||| S:22762 E:22776 ||| DT
respective  ||| S:22776 E:22787 ||| JJ
antisera ||| S:22787 E:22795 ||| NN
.  ||| S:22795 E:22797 ||| .
Immunocomplexes  ||| S:22797 E:22813 ||| NNP
were  ||| S:22813 E:22818 ||| VBD
collected  ||| S:22818 E:22828 ||| VBN
by  ||| S:22828 E:22841 ||| IN
binding  ||| S:22841 E:22849 ||| VBG
to  ||| S:22849 E:22852 ||| TO
protein  ||| S:22852 E:22860 ||| VB
A  ||| S:22860 E:22862 ||| DT
or  ||| S:22862 E:22865 ||| CC
G  ||| S:22865 E:22867 ||| NNP
beads ||| S:22867 E:22872 ||| NN
,  ||| S:22872 E:22874 ||| ,
washed  ||| S:22874 E:22881 ||| VBN
and  ||| S:22881 E:22885 ||| CC
analyzed  ||| S:22885 E:22894 ||| VBD
by  ||| S:22894 E:22907 ||| IN
immunoblotting  ||| S:22907 E:22922 ||| VBG
as  ||| S:22922 E:22925 ||| RB
described  ||| S:22925 E:22935 ||| VBN
[  ||| S:22935 E:22937 ||| -LRB-
33 ||| S:22937 E:22939 ||| CD
] ||| S:22939 E:22940 ||| -RRB-
.  ||| S:22940 E:22952 ||| .
For  ||| S:22952 E:22956 ||| IN
indirect  ||| S:22956 E:22965 ||| JJ
immunofluorescence  ||| S:22965 E:22984 ||| JJ
staining ||| S:22984 E:22992 ||| NN
,  ||| S:22992 E:22994 ||| ,
cells  ||| S:22994 E:23000 ||| NNS
were  ||| S:23000 E:23015 ||| VBD
fixed  ||| S:23015 E:23021 ||| VBN
in  ||| S:23021 E:23024 ||| IN
freshly  ||| S:23024 E:23032 ||| RB
prepared  ||| S:23032 E:23041 ||| VBN
3.7 ||| S:23041 E:23044 ||| CD
%  ||| S:23044 E:23046 ||| NN
para-formaldehyde  ||| S:23046 E:23064 ||| NN
for  ||| S:23064 E:23068 ||| IN
1h  ||| S:23068 E:23081 ||| CD
at  ||| S:23081 E:23084 ||| IN
30°C ||| S:23084 E:23088 ||| CD
.  ||| S:23088 E:23090 ||| .
Cells  ||| S:23090 E:23096 ||| NNS
were  ||| S:23096 E:23101 ||| VBD
washed  ||| S:23101 E:23108 ||| VBN
in  ||| S:23108 E:23111 ||| IN
PEM  ||| S:23111 E:23115 ||| NNP
( ||| S:23115 E:23116 ||| -LRB-
100  ||| S:23116 E:23120 ||| CD
mM  ||| S:23120 E:23123 ||| JJ
Pipes  ||| S:23123 E:23129 ||| NNP
pH6.9 ||| S:23129 E:23134 ||| NNP
,  ||| S:23134 E:23136 ||| ,
1  ||| S:23136 E:23148 ||| CD
mM  ||| S:23148 E:23151 ||| JJ
EGTA ||| S:23151 E:23155 ||| NNP
,  ||| S:23155 E:23157 ||| ,
1  ||| S:23157 E:23159 ||| CD
mM  ||| S:23159 E:23162 ||| JJ
MgSO  ||| S:23162 E:23178 ||| JJ
4  ||| S:23178 E:23180 ||| CD
) ||| S:23180 E:23181 ||| -RRB-
,  ||| S:23181 E:23183 ||| ,
and  ||| S:23183 E:23187 ||| CC
digested  ||| S:23187 E:23196 ||| VBN
with  ||| S:23196 E:23201 ||| IN
Novozyme  ||| S:23201 E:23210 ||| NNP
( ||| S:23210 E:23211 ||| -LRB-
0.5  ||| S:23211 E:23225 ||| CD
mg ||| S:23225 E:23227 ||| CD
/ ||| S:23227 E:23228 ||| CD
ml ||| S:23228 E:23230 ||| NN
,  ||| S:23230 E:23232 ||| ,
Sigma ||| S:23232 E:23237 ||| NNP
)  ||| S:23237 E:23239 ||| -RRB-
and  ||| S:23239 E:23243 ||| CC
Zymolyase  ||| S:23243 E:23253 ||| NNP
( ||| S:23253 E:23254 ||| -LRB-
0.5  ||| S:23254 E:23258 ||| CD
mg ||| S:23258 E:23260 ||| CD
/ ||| S:23260 E:23261 ||| CD
ml ||| S:23261 E:23263 ||| NN
,  ||| S:23263 E:23265 ||| ,
US  ||| S:23265 E:23268 ||| NNP
Biological ||| S:23268 E:23278 ||| NNP
)  ||| S:23278 E:23280 ||| -RRB-
in  ||| S:23280 E:23293 ||| IN
PEM ||| S:23293 E:23296 ||| NNP
,  ||| S:23296 E:23298 ||| ,
1M  ||| S:23298 E:23301 ||| CD
sorbitol ||| S:23301 E:23309 ||| NNS
.  ||| S:23309 E:23311 ||| .
Unspecific  ||| S:23311 E:23322 ||| JJ
epitopes  ||| S:23322 E:23331 ||| NN
were  ||| S:23331 E:23336 ||| VBD
blocked  ||| S:23336 E:23344 ||| VBN
by  ||| S:23344 E:23357 ||| IN
incubation  ||| S:23357 E:23368 ||| NN
in  ||| S:23368 E:23371 ||| IN
PEM-BAL  ||| S:23371 E:23379 ||| NNP
( ||| S:23379 E:23380 ||| -LRB-
PEM  ||| S:23380 E:23384 ||| NNP
plus  ||| S:23384 E:23389 ||| CC
1 ||| S:23389 E:23390 ||| CD
%  ||| S:23390 E:23392 ||| NN
BSA ||| S:23392 E:23395 ||| NNP
,  ||| S:23395 E:23397 ||| ,
0.1 ||| S:23397 E:23400 ||| CD
%  ||| S:23400 E:23402 ||| NN
Na-azide ||| S:23402 E:23410 ||| NN
,  ||| S:23410 E:23422 ||| ,
0.1  ||| S:23422 E:23426 ||| CD
M  ||| S:23426 E:23428 ||| NNP
L-lysine  ||| S:23428 E:23437 ||| NNP
HCl ||| S:23437 E:23440 ||| NNP
)  ||| S:23440 E:23442 ||| -RRB-
for  ||| S:23442 E:23446 ||| IN
1h ||| S:23446 E:23448 ||| CD
.  ||| S:23448 E:23450 ||| .
Incubation  ||| S:23450 E:23461 ||| NNP
with  ||| S:23461 E:23466 ||| IN
monoclonal  ||| S:23466 E:23487 ||| JJ
Myc  ||| S:23487 E:23491 ||| JJ
antibodies  ||| S:23491 E:23502 ||| NNS
diluted  ||| S:23502 E:23510 ||| VBN
in  ||| S:23510 E:23513 ||| IN
PEM-BAL  ||| S:23513 E:23521 ||| NNP
was  ||| S:23521 E:23525 ||| VBD
done  ||| S:23525 E:23530 ||| VBN
overnight ||| S:23530 E:23539 ||| JJ
,  ||| S:23539 E:23551 ||| ,
followed  ||| S:23551 E:23560 ||| VBN
by  ||| S:23560 E:23563 ||| IN
three  ||| S:23563 E:23569 ||| CD
washes  ||| S:23569 E:23576 ||| NN
in  ||| S:23576 E:23579 ||| IN
PEM-BAL ||| S:23579 E:23586 ||| JJ
.  ||| S:23586 E:23588 ||| .
An  ||| S:23588 E:23591 ||| DT
overnight  ||| S:23591 E:23611 ||| JJ
incubation  ||| S:23611 E:23622 ||| NN
with  ||| S:23622 E:23627 ||| IN
TRITC-labeled  ||| S:23627 E:23641 ||| JJ
anti  ||| S:23641 E:23646 ||| JJ
mouse  ||| S:23646 E:23652 ||| NN
antibodies  ||| S:23652 E:23663 ||| NNS
was  ||| S:23663 E:23677 ||| VBD
followed  ||| S:23677 E:23686 ||| VBN
by  ||| S:23686 E:23689 ||| IN
washing  ||| S:23689 E:23697 ||| VBG
and  ||| S:23697 E:23701 ||| CC
mounting  ||| S:23701 E:23710 ||| VBG
on  ||| S:23710 E:23713 ||| IN
polylysine  ||| S:23713 E:23724 ||| JJ
coated  ||| S:23724 E:23741 ||| JJ
coverslips ||| S:23741 E:23751 ||| NN
.  ||| S:23751 E:23753 ||| .
Cell  ||| S:23753 E:23758 ||| NN
nuclei  ||| S:23758 E:23765 ||| NNS
were  ||| S:23765 E:23770 ||| VBD
counterstained  ||| S:23770 E:23785 ||| VBN
with  ||| S:23785 E:23790 ||| IN
DAPI ||| S:23790 E:23794 ||| NNP
.  ||| S:23794 E:23806 ||| .
Photomicrographs  ||| S:23806 E:23823 ||| NNP
were  ||| S:23823 E:23828 ||| VBD
obtained  ||| S:23828 E:23837 ||| VBN
with  ||| S:23837 E:23842 ||| IN
a  ||| S:23842 E:23844 ||| DT
CCD  ||| S:23844 E:23848 ||| NNP
camera  ||| S:23848 E:23855 ||| NN
mounted  ||| S:23855 E:23873 ||| VBD
on  ||| S:23873 E:23876 ||| IN
a  ||| S:23876 E:23878 ||| DT
Nikon  ||| S:23878 E:23884 ||| NNP
E600  ||| S:23884 E:23889 ||| NNP
epifluorescence  ||| S:23889 E:23905 ||| JJ
microscope ||| S:23905 E:23915 ||| NN
.  ||| S:23915 E:23917 ||| .
Brightness  ||| S:23917 E:23938 ||| NNP
and  ||| S:23938 E:23942 ||| CC
contrast  ||| S:23942 E:23951 ||| NN
were  ||| S:23951 E:23956 ||| VBD
adjusted  ||| S:23956 E:23965 ||| VBN
in  ||| S:23965 E:23968 ||| IN
Adobe  ||| S:23968 E:23974 ||| NNP
Photoshop  ||| S:23974 E:23984 ||| NNP
5.0 ||| S:23984 E:23987 ||| NNP
.  ||| S:23987 E:24017 ||| .
In  ||| S:24017 E:24020 ||| IN
vitroubiquitylation  ||| S:24020 E:24040 ||| JJ
assay  ||| S:24040 E:24056 ||| NN
For  ||| S:24056 E:24060 ||| IN
ubiquitylation  ||| S:24060 E:24075 ||| JJ
reactions ||| S:24075 E:24084 ||| NNS
,  ||| S:24084 E:24086 ||| ,
Pcu3p-Myc  ||| S:24086 E:24096 ||| CD
complexes  ||| S:24096 E:24106 ||| NNS
were  ||| S:24106 E:24121 ||| VBD
immunoprecipitated  ||| S:24121 E:24140 ||| VBN
from  ||| S:24140 E:24145 ||| IN
100  ||| S:24145 E:24149 ||| CD
-  ||| S:24149 E:24151 ||| :
200  ||| S:24151 E:24155 ||| CD
ug  ||| S:24155 E:24158 ||| CD
total  ||| S:24158 E:24164 ||| JJ
cell  ||| S:24164 E:24169 ||| NN
lysates  ||| S:24169 E:24187 ||| VBZ
prepared  ||| S:24187 E:24196 ||| VBN
as  ||| S:24196 E:24199 ||| RB
described  ||| S:24199 E:24209 ||| VBN
above ||| S:24209 E:24214 ||| IN
.  ||| S:24214 E:24216 ||| .
Precipiates  ||| S:24216 E:24228 ||| NNP
were  ||| S:24228 E:24233 ||| VBD
washed  ||| S:24233 E:24240 ||| VBN
four  ||| S:24240 E:24255 ||| CD
times  ||| S:24255 E:24261 ||| NNS
in  ||| S:24261 E:24264 ||| IN
20  ||| S:24264 E:24267 ||| CD
mM  ||| S:24267 E:24270 ||| JJ
Tris ||| S:24270 E:24274 ||| NNP
/ ||| S:24274 E:24275 ||| NNP
HCl ||| S:24275 E:24278 ||| NNP
,  ||| S:24278 E:24280 ||| ,
pH  ||| S:24280 E:24283 ||| JJ
7.4 ||| S:24283 E:24286 ||| CD
;  ||| S:24286 E:24288 ||| :
150  ||| S:24288 E:24292 ||| CD
mM  ||| S:24292 E:24295 ||| JJ
NaCl ||| S:24295 E:24299 ||| NN
;  ||| S:24299 E:24301 ||| :
0.5  ||| S:24301 E:24305 ||| CD
%  ||| S:24305 E:24317 ||| NN
Triton  ||| S:24317 E:24324 ||| NNP
X-100 ||| S:24324 E:24329 ||| NNP
,  ||| S:24329 E:24331 ||| ,
10  ||| S:24331 E:24334 ||| CD
μg ||| S:24334 E:24336 ||| CD
/ ||| S:24336 E:24337 ||| CD
ml  ||| S:24337 E:24340 ||| JJ
leupeptin ||| S:24340 E:24349 ||| NN
,  ||| S:24349 E:24351 ||| ,
10  ||| S:24351 E:24354 ||| CD
μg ||| S:24354 E:24356 ||| CD
/ ||| S:24356 E:24357 ||| CD
ml  ||| S:24357 E:24360 ||| JJ
pepstatin ||| S:24360 E:24369 ||| NN
,  ||| S:24369 E:24371 ||| ,
5  ||| S:24371 E:24383 ||| CD
μg ||| S:24383 E:24385 ||| CD
/ ||| S:24385 E:24386 ||| CD
ml  ||| S:24386 E:24389 ||| JJ
aprotinin ||| S:24389 E:24398 ||| NN
,  ||| S:24398 E:24400 ||| ,
1  ||| S:24400 E:24402 ||| CD
mM  ||| S:24402 E:24405 ||| JJ
PMS ||| S:24405 E:24408 ||| NNP
,  ||| S:24408 E:24410 ||| ,
and  ||| S:24410 E:24414 ||| CC
equilibrated  ||| S:24414 E:24427 ||| NN
in  ||| S:24427 E:24430 ||| IN
20  ||| S:24430 E:24433 ||| CD
mM  ||| S:24433 E:24446 ||| JJ
HEPES ||| S:24446 E:24451 ||| NNP
,  ||| S:24451 E:24453 ||| ,
pH  ||| S:24453 E:24456 ||| JJ
7.4 ||| S:24456 E:24459 ||| CD
,  ||| S:24459 E:24461 ||| ,
100  ||| S:24461 E:24465 ||| CD
mM  ||| S:24465 E:24468 ||| JJ
potassium  ||| S:24468 E:24478 ||| JJ
acetate ||| S:24478 E:24485 ||| NN
,  ||| S:24485 E:24487 ||| ,
1  ||| S:24487 E:24489 ||| CD
mM  ||| S:24489 E:24492 ||| JJ
DTT ||| S:24492 E:24495 ||| NNP
.  ||| S:24495 E:24497 ||| .
The  ||| S:24497 E:24511 ||| DT
reaction  ||| S:24511 E:24520 ||| NN
was  ||| S:24520 E:24524 ||| VBD
started  ||| S:24524 E:24532 ||| VBN
by  ||| S:24532 E:24535 ||| IN
the  ||| S:24535 E:24539 ||| DT
addition  ||| S:24539 E:24548 ||| NN
of  ||| S:24548 E:24551 ||| IN
a  ||| S:24551 E:24553 ||| DT
cocktail  ||| S:24553 E:24562 ||| NN
of  ||| S:24562 E:24565 ||| IN
8  ||| S:24565 E:24577 ||| CD
μM  ||| S:24577 E:24580 ||| JJ
ubiquitin ||| S:24580 E:24589 ||| NN
,  ||| S:24589 E:24591 ||| ,
ATP  ||| S:24591 E:24595 ||| NNP
regenerating  ||| S:24595 E:24608 ||| JJ
system  ||| S:24608 E:24615 ||| NN
( ||| S:24615 E:24616 ||| -LRB-
2  ||| S:24616 E:24618 ||| CD
mM  ||| S:24618 E:24621 ||| JJ
HEPES  ||| S:24621 E:24627 ||| NN
at  ||| S:24627 E:24630 ||| IN
pH  ||| S:24630 E:24643 ||| JJ
7.4 ||| S:24643 E:24646 ||| CD
,  ||| S:24646 E:24648 ||| ,
1  ||| S:24648 E:24650 ||| CD
mM  ||| S:24650 E:24653 ||| JJ
ATP ||| S:24653 E:24656 ||| NNP
,  ||| S:24656 E:24658 ||| ,
30  ||| S:24658 E:24661 ||| CD
mM  ||| S:24661 E:24664 ||| JJ
creatine  ||| S:24664 E:24673 ||| JJ
phosphate ||| S:24673 E:24682 ||| NN
,  ||| S:24682 E:24684 ||| ,
1  ||| S:24684 E:24686 ||| CD
mM  ||| S:24686 E:24689 ||| JJ
magnesium  ||| S:24689 E:24709 ||| JJ
acetate ||| S:24709 E:24716 ||| NN
,  ||| S:24716 E:24718 ||| ,
0.15  ||| S:24718 E:24723 ||| FW
mg ||| S:24723 E:24725 ||| FW
/ ||| S:24725 E:24726 ||| FW
ml  ||| S:24726 E:24729 ||| FW
creatine  ||| S:24729 E:24738 ||| FW
kinase ||| S:24738 E:24744 ||| FW
) ||| S:24744 E:24745 ||| -RRB-
,  ||| S:24745 E:24747 ||| ,
reaction  ||| S:24747 E:24756 ||| NN
buffer  ||| S:24756 E:24763 ||| NN
( ||| S:24763 E:24764 ||| -LRB-
4  ||| S:24764 E:24776 ||| CD
mM  ||| S:24776 E:24779 ||| JJ
magnesium  ||| S:24779 E:24789 ||| JJ
acetate ||| S:24789 E:24796 ||| NN
,  ||| S:24796 E:24798 ||| ,
1  ||| S:24798 E:24800 ||| CD
mM  ||| S:24800 E:24803 ||| JJ
DTT ||| S:24803 E:24806 ||| NNP
) ||| S:24806 E:24807 ||| -RRB-
,  ||| S:24807 E:24809 ||| ,
500  ||| S:24809 E:24813 ||| CD
nM  ||| S:24813 E:24816 ||| JJ
bacterially  ||| S:24816 E:24838 ||| NN
expressed  ||| S:24838 E:24848 ||| VBD
6xHis-UBCs ||| S:24848 E:24858 ||| CD
,  ||| S:24858 E:24860 ||| ,
100  ||| S:24860 E:24864 ||| CD
nM  ||| S:24864 E:24867 ||| JJ
6xHis-tagged  ||| S:24867 E:24880 ||| CD
human  ||| S:24880 E:24886 ||| JJ
E1 ||| S:24886 E:24888 ||| NN
,  ||| S:24888 E:24890 ||| ,
and  ||| S:24890 E:24904 ||| CC
0.5  ||| S:24904 E:24908 ||| CD
μM  ||| S:24908 E:24911 ||| JJ
ubiquitin  ||| S:24911 E:24921 ||| JJ
aldehyde  ||| S:24921 E:24930 ||| NN
in  ||| S:24930 E:24933 ||| IN
a  ||| S:24933 E:24935 ||| DT
volume  ||| S:24935 E:24942 ||| NN
of  ||| S:24942 E:24945 ||| IN
15  ||| S:24945 E:24948 ||| CD
μl ||| S:24948 E:24950 ||| NNS
.  ||| S:24950 E:24952 ||| .
After  ||| S:24952 E:24958 ||| IN
90  ||| S:24958 E:24971 ||| CD
min  ||| S:24971 E:24975 ||| NN
at  ||| S:24975 E:24978 ||| IN
30°C ||| S:24978 E:24982 ||| NNP
,  ||| S:24982 E:24984 ||| ,
the  ||| S:24984 E:24988 ||| DT
reaction  ||| S:24988 E:24997 ||| NN
was  ||| S:24997 E:25001 ||| VBD
terminated  ||| S:25001 E:25012 ||| VBN
by  ||| S:25012 E:25015 ||| IN
the  ||| S:25015 E:25019 ||| DT
addition  ||| S:25019 E:25038 ||| NN
5  ||| S:25038 E:25040 ||| CD
×  ||| S:25040 E:25042 ||| CD
SDS  ||| S:25042 E:25046 ||| JJ
sample  ||| S:25046 E:25053 ||| NN
buffer ||| S:25053 E:25059 ||| NN
.  ||| S:25059 E:25061 ||| .
Samples  ||| S:25061 E:25069 ||| NNS
were  ||| S:25069 E:25074 ||| VBD
separated  ||| S:25074 E:25084 ||| VBN
on  ||| S:25084 E:25087 ||| IN
11  ||| S:25087 E:25090 ||| CD
%  ||| S:25090 E:25102 ||| NN
SDS-polyacrylamide  ||| S:25102 E:25121 ||| JJ
gels  ||| S:25121 E:25126 ||| NN
and  ||| S:25126 E:25130 ||| CC
analyzed  ||| S:25130 E:25139 ||| VBD
by  ||| S:25139 E:25142 ||| IN
immunoblotting  ||| S:25142 E:25167 ||| NN
with  ||| S:25167 E:25172 ||| IN
ubiquitin  ||| S:25172 E:25182 ||| JJ
antibodies  ||| S:25182 E:25193 ||| NNS
( ||| S:25193 E:25194 ||| -LRB-
Zymed ||| S:25194 E:25199 ||| NNP
) ||| S:25199 E:25200 ||| -RRB-
.  ||| S:25200 E:25233 ||| .
Abbreviations  ||| S:25233 E:25255 ||| NNP
CSN ||| S:25255 E:25258 ||| NNP
:  ||| S:25258 E:25260 ||| :
COP9 ||| S:25260 E:25264 ||| FW
/ ||| S:25264 E:25265 ||| FW
signalosome  ||| S:25265 E:25285 ||| FW
GST ||| S:25285 E:25288 ||| FW
:  ||| S:25288 E:25290 ||| :
Glutathione  ||| S:25290 E:25302 ||| NNP
S-transferase  ||| S:25302 E:25324 ||| NNP
HA ||| S:25324 E:25326 ||| NNP
:  ||| S:25326 E:25328 ||| :
hemagglutinin  ||| S:25328 E:25350 ||| JJ
SCF ||| S:25350 E:25353 ||| NNP
:  ||| S:25353 E:25355 ||| :
SKP1 ||| S:25355 E:25359 ||| FW
/ ||| S:25359 E:25360 ||| FW
Cullin ||| S:25360 E:25366 ||| FW
/ ||| S:25366 E:25367 ||| FW
F-box  ||| S:25367 E:25373 ||| FW
protein  ||| S:25373 E:25381 ||| FW
complex  ||| S:25381 E:25397 ||| FW
UBC ||| S:25397 E:25400 ||| FW
:  ||| S:25400 E:25402 ||| :
Ubiquitin-conjugating  ||| S:25402 E:25424 ||| FW
enzyme  ||| S:25424 E:25446 ||| FW
